{ "version": "2.2", "instance": { "ohi-20260630x10q.htm": { "nsprefix": "ohi", "nsuri": "http://www.omegahealthcare.com/20260630", "dts": { "schema": { "local": [ "ohi-20260630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/currency/2025/currency-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "ohi-20260630_cal.xml" ] }, "definitionLink": { "local": [ "ohi-20260630_def.xml" ] }, "labelLink": { "local": [ "ohi-20260630_lab.xml" ] }, "presentationLink": { "local": [ "ohi-20260630_pre.xml" ] }, "inline": { "local": [ "ohi-20260630x10q.htm" ] } }, "keyStandard": 298, "keyCustom": 108, "axisStandard": 34, "axisCustom": 4, "memberStandard": 55, "memberCustom": 125, "hidden": { "total": 28, "http://xbrl.sec.gov/dei/2025": 4, "http://fasb.org/us-gaap/2025": 17, "http://www.omegahealthcare.com/20260630": 7 }, "contextCount": 621, "entityCount": 1, "segmentCount": 186, "elementCount": 887, "unitCount": 12, "baseTaxonomies": { "http://fasb.org/us-gaap/2025": 1434, "http://xbrl.sec.gov/dei/2025": 29, "http://xbrl.sec.gov/ecd/2025": 4, "http://fasb.org/srt/2025": 1 }, "report": { "R1": { "role": "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation", "longName": "995200090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets", "longName": "995200100 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:InvestmentBuildingAndBuildingImprovements", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:InvestmentBuildingAndBuildingImprovements", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals", "longName": "995200105 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_UjqFm7WYjUiMOqiFjA7Afw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_UjqFm7WYjUiMOqiFjA7Afw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations", "longName": "995200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:LeaseIncome", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:OperatingExpenses", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R5": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome", "longName": "995200300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R6": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity", "longName": "995200400 - Statement - CONSOLIDATED STATEMENTS OF EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_ParentMember_BfeP5NUcO0O0ebbiCA7I5w", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_StatementEquityComponentsAxis_us-gaap_ParentMember_BfeP5NUcO0O0ebbiCA7I5w", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquityParentheticals", "longName": "995200405 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (Parentheticals)", "shortName": "CONSOLIDATED STATEMENTS OF EQUITY (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "Unit_Divide_USD_shares_UjqFm7WYjUiMOqiFjA7Afw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "995200500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:StraightLineRentAndOtherWriteOffs", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R9": { "role": "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies", "longName": "995210101 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateAssets", "longName": "995210201 - Disclosure - REAL ESTATE ASSETS", "shortName": "REAL ESTATE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairments", "longName": "995210301 - Disclosure - ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS", "shortName": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:AssetsHeldForSaleTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:AssetsHeldForSaleTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivables", "longName": "995210401 - Disclosure - CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES", "shortName": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivable", "longName": "995210501 - Disclosure - REAL ESTATE LOANS RECEIVABLE", "shortName": "REAL ESTATE LOANS RECEIVABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:FinancingReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:FinancingReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivable", "longName": "995210601 - Disclosure - NON-REAL ESTATE LOANS RECEIVABLE", "shortName": "NON-REAL ESTATE LOANS RECEIVABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLosses", "longName": "995210701 - Disclosure - ALLOWANCE FOR CREDIT LOSSES", "shortName": "ALLOWANCE FOR CREDIT LOSSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:AllowanceForCreditLossesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:AllowanceForCreditLossesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntities", "longName": "995210801 - Disclosure - VARIABLE INTEREST ENTITIES", "shortName": "VARIABLE INTEREST ENTITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntities", "longName": "995210901 - Disclosure - INVESTMENTS IN UNCONSOLIDATED ENTITIES", "shortName": "INVESTMENTS IN UNCONSOLIDATED ENTITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangibles", "longName": "995211001 - Disclosure - GOODWILL AND OTHER INTANGIBLES", "shortName": "GOODWILL AND OTHER INTANGIBLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRisk", "longName": "995211101 - Disclosure - CONCENTRATION OF RISK", "shortName": "CONCENTRATION OF RISK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquity", "longName": "995211201 - Disclosure - STOCKHOLDERS' EQUITY", "shortName": "STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.omegahealthcare.com/role/DisclosureTaxes", "longName": "995211301 - Disclosure - TAXES", "shortName": "TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensation", "longName": "995211401 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangements", "longName": "995211501 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS", "shortName": "BORROWING ACTIVITIES AND ARRANGEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedging", "longName": "995211601 - Disclosure - DERIVATIVES AND HEDGING", "shortName": "DERIVATIVES AND HEDGING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.omegahealthcare.com/role/DisclosureFinancialInstruments", "longName": "995211701 - Disclosure - FINANCIAL INSTRUMENTS", "shortName": "FINANCIAL INSTRUMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingencies", "longName": "995211801 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.omegahealthcare.com/role/DisclosureEarningsPerShare", "longName": "995211901 - Disclosure - EARNINGS PER SHARE", "shortName": "EARNINGS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlows", "longName": "995212001 - Disclosure - SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.omegahealthcare.com/role/DisclosureSegments", "longName": "995212101 - Disclosure - SEGMENTS", "shortName": "SEGMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.omegahealthcare.com/role/DisclosureSubsequentEvents", "longName": "995212201 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R31": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": null }, "R32": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicy", "longName": "99920102 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policy)", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policy)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "33", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsTables", "longName": "99930203 - Disclosure - REAL ESTATE ASSETS (Tables)", "shortName": "REAL ESTATE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:OperatingAndDirectFinanceLeaseLeaseIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:OperatingAndDirectFinanceLeaseLeaseIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsTables", "longName": "99930303 - Disclosure - ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Tables)", "shortName": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ohi:AssetsHeldForSaleTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ohi:AssetsHeldForSaleTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesTables", "longName": "99930403 - Disclosure - CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Tables)", "shortName": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:ScheduleOfAccountsReceivableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:ScheduleOfAccountsReceivableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables", "longName": "99930503 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Tables)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ohi_MortgageReceivablesAndOtherRealEstateLoansMember_7hSp2L2KikqkOQD9yl2DCw", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ohi_MortgageReceivablesAndOtherRealEstateLoansMember_7hSp2L2KikqkOQD9yl2DCw", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "longName": "99930603 - Disclosure - NON-REAL ESTATE LOANS RECEIVABLE (Tables)", "shortName": "NON-REAL ESTATE LOANS RECEIVABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_NotesReceivableMember_le6CC-GPFUux2W4qECNGYQ", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_NotesReceivableMember_le6CC-GPFUux2W4qECNGYQ", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesTables", "longName": "99930703 - Disclosure - ALLOWANCE FOR CREDIT LOSSES (Tables)", "shortName": "ALLOWANCE FOR CREDIT LOSSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:AllowanceForCreditLossesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:AllowanceForCreditLossesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesTables", "longName": "99930803 - Disclosure - VARIABLE INTEREST ENTITIES (Tables)", "shortName": "VARIABLE INTEREST ENTITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesTables", "longName": "99930903 - Disclosure - INVESTMENTS IN UNCONSOLIDATED ENTITIES (Tables)", "shortName": "INVESTMENTS IN UNCONSOLIDATED ENTITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesTables", "longName": "99931003 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables)", "shortName": "GOODWILL AND OTHER INTANGIBLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityTables", "longName": "99931203 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:ScheduleOfAtmIssuances", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "ohi:ScheduleOfAtmIssuances", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.omegahealthcare.com/role/DisclosureTaxesTables", "longName": "99931303 - Disclosure - TAXES (Tables)", "shortName": "TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationTables", "longName": "99931403 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsTables", "longName": "99931503 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)", "shortName": "BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingTables", "longName": "99931603 - Disclosure - DERIVATIVES AND HEDGING (Tables)", "shortName": "DERIVATIVES AND HEDGING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsTables", "longName": "99931703 - Disclosure - FINANCIAL INSTRUMENTS (Tables)", "shortName": "FINANCIAL INSTRUMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesTables", "longName": "99931803 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:OtherCommitmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:OtherCommitmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareTables", "longName": "99931903 - Disclosure - EARNINGS PER SHARE (Tables)", "shortName": "EARNINGS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsTables", "longName": "99932003 - Disclosure - SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Tables)", "shortName": "SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.omegahealthcare.com/role/DisclosureSegmentsTables", "longName": "99932103 - Disclosure - SEGMENTS (Tables)", "shortName": "SEGMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "longName": "99940101 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_ohi_IncomeStatementLineItemDisaggregationAxis_ohi_SeniorHousingExpensesMember_Kp1UKPeqeEiz5oO_nHxnMQ", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R54": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "longName": "99940201 - Disclosure - REAL ESTATE ASSET (Narrative) (Details)", "shortName": "REAL ESTATE ASSET (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails", "longName": "99940202 - Disclosure - REAL ESTATE ASSETS (Schedule of operating and direct financing lease income) (Details)", "shortName": "REAL ESTATE ASSETS (Schedule of operating and direct financing lease income) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:OperatingAndDirectFinanceLeaseLeaseIncomeTableTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:OperatingAndDirectFinanceLeaseLeaseIncomeTableTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "longName": "99940203 - Disclosure - REAL ESTATE ASSETS (Schedule of Significant Acquisitions) (Details)", "shortName": "REAL ESTATE ASSETS (Schedule of Significant Acquisitions) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_srt_StatementGeographicalAxis_country_GB_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_xg9q79APgUGlcXCLGsgT4g", "name": "us-gaap:PaymentsToAcquireRealEstate", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "td", "tr", "table", "us-gaap:AssetAcquisitionTableTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R57": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails", "longName": "99940204 - Disclosure - REAL ESTATE ASSETS (Summary of construction in progress and expenditure investments by segment) (Details)", "shortName": "REAL ESTATE ASSETS (Summary of construction in progress and expenditure investments by segment) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:PaymentsForCapitalImprovementsAndConstructionInProgess", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:ConstructionInProgressAndCapitalExpenditureInvestmentsTableTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:PaymentsForCapitalImprovementsAndConstructionInProgess", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:ConstructionInProgressAndCapitalExpenditureInvestmentsTableTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "longName": "99940301 - Disclosure - ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Schedule of Properties Held-for-Sale) (Details)", "shortName": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Schedule of Properties Held-for-Sale) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": null }, "R59": { "role": "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "longName": "99940302 - Disclosure - ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Asset Sales) (Details)", "shortName": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Asset Sales) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_srt_StatementGeographicalAxis_ohi_MarylandAndWestVirginiaMember_aRYohlLlfESYacUsjm7vgA", "name": "ohi:GrossProceedsFromSaleOfPropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ohi:AssetsHeldForSaleTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R60": { "role": "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "longName": "99940303 - Disclosure - ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Real Estate Impairment) (Details)", "shortName": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Real Estate Impairment) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "Duration_4_1_2025_To_6_30_2025_JeUZzytkeUqdDgmez5H89Q", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2025_To_6_30_2025_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_ohi_ThreeFacilitiesMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_0Vgw4Ayal0agFv0FAmYWPg", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ohi:AssetsHeldForSaleTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R61": { "role": "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesScheduleOfNetAccountsReceivableDetails", "longName": "99940401 - Disclosure - CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Schedule of Net Accounts Receivable) (Details)", "shortName": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Schedule of Net Accounts Receivable) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:ContractWithCustomerAssetNet", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:ScheduleOfAccountsReceivableTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "ohi:StraightLineReceivables", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:ScheduleOfAccountsReceivableTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R62": { "role": "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "longName": "99940402 - Disclosure - CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Cash Basis Operators and Straight Line Receivable Write Offs Narrative) (Details)", "shortName": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Cash Basis Operators and Straight Line Receivable Write Offs Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "ohi:NumberOfOperators", "unitRef": "Unit_Standard_contract_-9myLSF0g0GlyAhhOSYxIA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:NumberOfOperatorsPlacedOnCashBasis", "unitRef": "Unit_Standard_item_vR4-ljh09E66TfxE2OqAlA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R63": { "role": "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "longName": "99940404 - Disclosure - CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Operator Collectibility - Maplewood) (Details)", "shortName": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Operator Collectibility - Maplewood) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:FinancingReceivableNonaccrualInterestIncome", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_dei_LegalEntityAxis_ohi_MaplewoodRealEstateHoldingsMember_tp8hJScnnkKLZobEQ07ucA", "name": "ohi:DeferredAggregateRent", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R64": { "role": "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "longName": "99940405 - Disclosure - CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Operator Collectibility - Genesis) (Details)", "shortName": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES (Operator Collectibility - Genesis) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:RestrictedCashAndCashEquivalents", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_dei_LegalEntityAxis_ohi_GenesisHealthcareMember_cv8CebunzkKltOHMe2ATXw", "name": "us-gaap:OperatingLeaseLeaseIncome", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R65": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "longName": "99940501 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Narrative) (Details)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_MortgageReceivablesMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_FuH3tH8iL0C8oY2dDjqV0Q", "name": "ohi:NumberOfFixedRateMortgage", "unitRef": "Unit_Standard_item_vR4-ljh09E66TfxE2OqAlA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:FinancingReceivablesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R66": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "longName": "99940502 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Schedule of Receivables) (Details)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Schedule of Receivables) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_MortgageReceivablesMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_Mh15a649-0iTM_e7Fmq6Og", "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R67": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "longName": "99940503 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Summary of investments income) (Details)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Summary of investments income) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:InterestAndFeeIncomeLoansAndLeases", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_ohi_InvestmentCharacteristicTypeAxis_ohi_InvestmentTypeCharacteristicRealEstateRelatedLoansMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_OuzvZrFjRUq8uUL6xYK0fQ", "name": "us-gaap:InterestAndFeeIncomeLoansAndLeases", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:InterestAndOtherIncomeTableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R68": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "longName": "99940504 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Loan activity) (Details)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Loan activity) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:PaymentsToAcquireLoansReceivable", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_ohi_InvestmentCharacteristicTypeAxis_ohi_InvestmentTypeCharacteristicRealEstateRelatedLoansMember_1NdrLnLVdU6WwaSHPMpXDw", "name": "ohi:PaymentsToAcquireLoanReceivableCollectionOfLoanPrincipalNet", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R69": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "longName": "99940505 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Maplewood Revolving Credit Facility Narrative) (Details)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Maplewood Revolving Credit Facility Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:InterestAndFeeIncomeLoansAndLeases", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_dei_LegalEntityAxis_ohi_MaplewoodRealEstateHoldingsMember_ohi_InvestmentCharacteristicTypeAxis_ohi_InvestmentTypeCharacteristicRealEstateRelatedLoansMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ohi_RevolvingCreditFacilityReceivableMember_srDYeo8FiUqBeQooB3tL1A", "name": "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R70": { "role": "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "longName": "99940506 - Disclosure - REAL ESTATE LOANS RECEIVABLE (Canadian Development Loan) (Details)", "shortName": "REAL ESTATE LOANS RECEIVABLE (Canadian Development Loan) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:ContractualObligation", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_srt_StatementGeographicalAxis_country_CA_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_LoansReceivableMember_b8pT7oyegUu5SreBdA4stA", "name": "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R71": { "role": "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "longName": "99940601 - Disclosure - NON-REAL ESTATE LOANS RECEIVABLE (Narrative) (Details)", "shortName": "NON-REAL ESTATE LOANS RECEIVABLE (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:InterestAndFeeIncomeLoansAndLeases", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_ohi_InvestmentCharacteristicTypeAxis_ohi_InvestmentTypeCharacteristicNonRealEstateRelatedLoansMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_BGVde2SlBkiP3260OXkm5g", "name": "us-gaap:InterestAndFeeIncomeLoansAndLeases", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R72": { "role": "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "longName": "99940602 - Disclosure - NON-REAL ESTATE LOANS RECEIVABLE (Schedule of receivables) (Details)", "shortName": "NON-REAL ESTATE LOANS RECEIVABLE (Schedule of receivables) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:AccountsAndNotesReceivableNet", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_NotesReceivableMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_t1mUdCkJ3k2LjUBPpWbL9Q", "name": "us-gaap:AccountsAndNotesReceivableNet", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R73": { "role": "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "longName": "99940603 - Disclosure - NON-REAL ESTATE LOANS RECEIVABLE (Loan activity) (Details)", "shortName": "NON-REAL ESTATE LOANS RECEIVABLE (Loan activity) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:PaymentsToAcquireLoansReceivable", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_ohi_InvestmentCharacteristicTypeAxis_ohi_InvestmentTypeCharacteristicNonRealEstateRelatedLoansMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_BGVde2SlBkiP3260OXkm5g", "name": "ohi:PaymentsToAcquireLoanReceivableCollectionOfLoanPrincipalNet", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ohi:ScheduleOfAccountsNotesLoansAndFinancingReceivableActivityDuringPeriodTableTextBlock", "us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R74": { "role": "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "longName": "99940604 - Disclosure - NON-REAL ESTATE LOANS RECEIVABLE (Genesis Non-Real Estate Loans) (Details)", "shortName": "NON-REAL ESTATE LOANS RECEIVABLE (Genesis Non-Real Estate Loans) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:ProceedsFromCollectionOfLoansReceivable", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_srt_CounterpartyNameAxis_ohi_OmegaHealthcareDipSuperPrioritySecuredLoanMember_a2lJ_wpmZUm2fnbYZyflTA", "name": "us-gaap:ProceedsFromCollectionOfLoansReceivable", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R75": { "role": "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesNarrativeDetails", "longName": "99940701 - Disclosure - ALLOWANCE FOR CREDIT LOSSES (Narrative) (Details)", "shortName": "ALLOWANCE FOR CREDIT LOSSES (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:AccruedInvestmentIncomeReceivable", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_AKFYxXxrdEaUQmxTJ0ijjw", "name": "us-gaap:AccruedInvestmentIncomeReceivable", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R76": { "role": "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "longName": "99940702 - Disclosure - ALLOWANCE FOR CREDIT LOSSES (Schedule of expected credit loss per segment) (Details)", "shortName": "ALLOWANCE FOR CREDIT LOSSES (Schedule of expected credit loss per segment) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "ohi:TotalReceivableAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:AllowanceForCreditLossesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R77": { "role": "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "longName": "99940703 - Disclosure - ALLOWANCE FOR CREDIT LOSSES (Schedule by segment balance by vintage and credit quality indicator) (Details)", "shortName": "ALLOWANCE FOR CREDIT LOSSES (Schedule by segment balance by vintage and credit quality indicator) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "ohi:TotalReceivableYearOneOriginatedCurrentFiscalYear", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "ohi:TotalReceivableYearOneOriginatedCurrentFiscalYear", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "longName": "99940801 - Disclosure - VARIABLE INTEREST ENTITIES (Schedule of variable interest entities) (Details)", "shortName": "VARIABLE INTEREST ENTITIES (Schedule of variable interest entities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:RealEstateInvestmentPropertyNet", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_liVkCojofUS8jkya9d3wXA", "name": "us-gaap:Assets", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R79": { "role": "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "longName": "99940901 - Disclosure - INVESTMENTS IN UNCONSOLIDATED ENTITIES (Schedule of equity method investments) (Details)", "shortName": "INVESTMENTS IN UNCONSOLIDATED ENTITIES (Schedule of equity method investments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ohi_SHHHoldingsLLCMember_us-gaap_StatementBusinessSegmentsAxis_ohi_TripleNetInvestmentsMember_opUTVpxLK02tun1Z99tO9A", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R80": { "role": "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "longName": "99940902 - Disclosure - INVESTMENTS IN UNCONSOLIDATED ENTITIES (SHH Holdings LLC) (Details)", "shortName": "INVESTMENTS IN UNCONSOLIDATED ENTITIES (SHH Holdings LLC) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_ohi_PropertyCategoryAxis_ohi_FacilitiesSoldMember_srt_CounterpartyNameAxis_ohi_SHHHoldingsLLCMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ohi_SkilledNursingFacilitiesMember_ptGKTP79B0ijNzFPWf1Omw", "name": "us-gaap:GainLossOnDispositionOfAssets", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R81": { "role": "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "longName": "99940903 - Disclosure - INVESTMENTS IN UNCONSOLIDATED ENTITIES (Saber Health Holdings LLC) (Details)", "shortName": "INVESTMENTS IN UNCONSOLIDATED ENTITIES (Saber Health Holdings LLC) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_1_1_2026_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ohi_SaberHealthcareHoldingsLLCMember_srYy1mrlKEuGoBSDdbXL1Q", "name": "us-gaap:PaymentsToAcquireInterestInJointVenture", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R82": { "role": "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "longName": "99941001 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Narrative) (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLES (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "ohi:BelowMarketLeaseWeightedAverageRemainingAmortizationPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_4_1_2026_fMkzV3NeQE-dO4AKGQwbsg", "name": "us-gaap:Goodwill", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R83": { "role": "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfReconciliationOfGoodwillDetails", "longName": "99941002 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Schedule of Reconciliation of Goodwill) (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLES (Schedule of Reconciliation of Goodwill) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "As_Of_12_31_2025_AKFYxXxrdEaUQmxTJ0ijjw", "name": "us-gaap:Goodwill", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R84": { "role": "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails", "longName": "99941003 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Schedule of Intangibles) (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLES (Schedule of Intangibles) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R85": { "role": "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "longName": "99941101 - Disclosure - CONCENTRATION OF RISK (Narrative) (Details)", "shortName": "CONCENTRATION OF RISK (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:NumberOfOperatorsThatMetOrExceededTenPercentThresholdForRevenues", "unitRef": "Unit_Standard_item_vR4-ljh09E66TfxE2OqAlA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "ohi:NumberOfOperatorsThatMetOrExceededTenPercentThresholdForRevenues", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R86": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails", "longName": "99941201 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Common Stock Dividends) (Details)", "shortName": "STOCKHOLDERS' EQUITY (Schedule of Common Stock Dividends) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "Unit_Divide_USD_shares_UjqFm7WYjUiMOqiFjA7Afw", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_us-gaap_DividendsAxis_ohi_O2025Q4DividendsMember_ZafAoyqc0Em8MP1BcS866g", "name": "us-gaap:DividendsPayableDateOfRecordDayMonthAndYear", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "table", "us-gaap:DividendsDeclaredTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R87": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails", "longName": "99941202 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of dividend reinvestment and common stock purchase plan) (Details)", "shortName": "STOCKHOLDERS' EQUITY (Schedule of dividend reinvestment and common stock purchase plan) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_us-gaap_SubsidiarySaleOfStockAxis_ohi_DividendReinvestmentAndCommonStockPurchasePlanMember_ZycpRcfEeEOBG6O6BBlGCg", "name": "us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan", "unitRef": "Unit_Standard_shares_q_2eDL7N5k-drGm74GZA7w", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:ScheduleOfDividendReinvestmentAndCommonStockPurchasePlanTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_us-gaap_SubsidiarySaleOfStockAxis_ohi_DividendReinvestmentAndCommonStockPurchasePlanMember_ZycpRcfEeEOBG6O6BBlGCg", "name": "us-gaap:StockIssuedDuringPeriodSharesDividendReinvestmentPlan", "unitRef": "Unit_Standard_shares_q_2eDL7N5k-drGm74GZA7w", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ohi:ScheduleOfDividendReinvestmentAndCommonStockPurchasePlanTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R88": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails", "longName": "99941203 - Disclosure - STOCKHOLDERS' EQUITY (At The Market Program Schedule and Narrative) (Details)", "shortName": "STOCKHOLDERS' EQUITY (At The Market Program Schedule and Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "Duration_4_1_2025_To_6_30_2025_us-gaap_SubsidiarySaleOfStockAxis_ohi_EquityShelfProgram125BillionMember_jxHS6e-cAkyLj2ZLc2Ax-Q", "name": "ohi:EquityDistributionAgreementGrossSalesPriceMaximum", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "ohi:EquityDistributionAgreementGrossSalesPriceMaximum", "p", "ohi:ScheduleOfAtmIssuances", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2025_To_6_30_2025_us-gaap_SubsidiarySaleOfStockAxis_ohi_EquityShelfProgram125BillionMember_jxHS6e-cAkyLj2ZLc2Ax-Q", "name": "ohi:EquityDistributionAgreementGrossSalesPriceMaximum", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "ohi:EquityDistributionAgreementGrossSalesPriceMaximum", "p", "ohi:ScheduleOfAtmIssuances", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R89": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityNoncontrollingInterestDetails", "longName": "99941204 - Disclosure - STOCKHOLDERS' EQUITY (Noncontrolling Interest) (Details)", "shortName": "STOCKHOLDERS' EQUITY (Noncontrolling Interest) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:MinorityInterestSharesRedeemed", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:MinorityInterestSharesRedeemed", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R90": { "role": "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails", "longName": "99941205 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)", "shortName": "STOCKHOLDERS' EQUITY (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R91": { "role": "http://www.omegahealthcare.com/role/DisclosureTaxesNarrativeDetails", "longName": "99941301 - Disclosure - TAXES (Narrative) (Details)", "shortName": "TAXES (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:DeferredTaxLiabilities", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:DeferredTaxLiabilities", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R92": { "role": "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails", "longName": "99941302 - Disclosure - TAXES (Schedule of components of income tax expense) (Details)", "shortName": "TAXES (Schedule of components of income tax expense) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R93": { "role": "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails", "longName": "99941401 - Disclosure - STOCK-BASED COMPENSATION (Summary of stock-based compensation expense) (Details)", "shortName": "STOCK-BASED COMPENSATION (Summary of stock-based compensation expense) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": null }, "R94": { "role": "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "longName": "99941402 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Details)", "shortName": "STOCK-BASED COMPENSATION (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_EmploymentContractsMember_LOx0l5mUnUqDWuELDznuzw", "name": "us-gaap:ShareBasedCompensation", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R95": { "role": "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "longName": "99941501 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Schedule of Borrowings) (Details)", "shortName": "BORROWING ACTIVITIES AND ARRANGEMENTS (Schedule of Borrowings) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:LineOfCredit", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:DebtInstrumentCovenantCompliance", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R96": { "role": "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "longName": "99941601 - Disclosure - DERIVATIVES AND HEDGING (Derivatives Designated as Hedging Instruments ) (Details)", "shortName": "DERIVATIVES AND HEDGING (Derivatives Designated as Hedging Instruments ) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_VpWFmpXUwEG36pI_2HdwbA", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "Unit_Standard_GBP_rAXzhGWFGkeJgRHFpS-ZQg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R97": { "role": "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "longName": "99941602 - Disclosure - DERIVATIVES AND HEDGING (Derivatives Not Designated as Hedging Instruments ) (Details)", "shortName": "DERIVATIVES AND HEDGING (Derivatives Not Designated as Hedging Instruments ) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "Duration_1_1_2026_To_6_30_2026_Eg59zg2RgUqJgzVc1fglug", "name": "us-gaap:PaymentsToAcquireRealEstate", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "td", "tr", "table", "us-gaap:AssetAcquisitionTableTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_ohi_DerivativeInstrumentNumberAxis_ohi_RelatedToTwoDerivativeInstrumentsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_IZ0oM8r31U-DTkSuDynlSA", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "Unit_Standard_GBP_rAXzhGWFGkeJgRHFpS-ZQg", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R98": { "role": "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails", "longName": "99941603 - Disclosure - DERIVATIVES AND HEDGING (Location and the fair value of derivative instruments designated as hedges) (Details)", "shortName": "DERIVATIVES AND HEDGING (Location and the fair value of derivative instruments designated as hedges) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_V-xe6OU7JkudYx7By8AIMw", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_V-xe6OU7JkudYx7By8AIMw", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R99": { "role": "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails", "longName": "99941701 - Disclosure - FINANCIAL INSTRUMENTS (Schedule of Financial Instruments) (Details)", "shortName": "FINANCIAL INSTRUMENTS (Schedule of Financial Instruments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_DebtInstrumentAxis_ohi_SeniorNotesDue2027Member_nMNg9SxnD0GLRoU2T5sZSg", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Unit_Standard_pure_I-1QkoXwc0iSF3qOVyokSA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_uuYiVdcZfESI7_3rGpo0Hg", "name": "us-gaap:NotesReceivableFairValueDisclosure", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R100": { "role": "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "longName": "99941801 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:ContractualObligation", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_LossContingenciesByNatureOfContingencyAxis_us-gaap_IndemnificationGuaranteeMember_oprC4KgQh0yuTOh3AOwwhw", "name": "us-gaap:OtherCommitment", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R101": { "role": "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "longName": "99941802 - Disclosure - COMMITMENTS AND CONTINGENCIES (Schedule of remaining commitments) (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES (Schedule of remaining commitments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:ContractualObligation", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2026_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ohi_RealEstateLoansReceivableMember_5ztvY_MKHUWFF3rTGkZ6yQ", "name": "us-gaap:ContractualObligation", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R102": { "role": "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "longName": "99941901 - Disclosure - EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Earnings per Share) (Details)", "shortName": "EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Earnings per Share) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:IncomeLossNonControllingInterestAndParticipatingShareAdjustments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R103": { "role": "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2", "longName": "99942001 - Disclosure - SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)2", "shortName": "SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Details)2", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2025_H-uhkLfkW0-H72Mfz-PAmw", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R104": { "role": "http://www.omegahealthcare.com/role/DisclosureSegmentsNarrativeDetails", "longName": "99942101 - Disclosure - SEGMENTS (Narrative) (Details)", "shortName": "SEGMENTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": null }, "R105": { "role": "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "longName": "99942102 - Disclosure - SEGMENTS - Reportable segments (Details)", "shortName": "SEGMENTS - Reportable segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "ohi:NetOperatingIncomeFromUnconsolidatedEntities", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } }, "R106": { "role": "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails", "longName": "99942103 - Disclosure - SEGMENTS - Significant expense categories by segment (Details)", "shortName": "SEGMENTS - Significant expense categories by segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:LaborAndRelatedExpense", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_1_2026_To_6_30_2026_tZqBKV97qEiAp9ULi6FsbA", "name": "us-gaap:LaborAndRelatedExpense", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true, "unique": true } }, "R107": { "role": "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "longName": "99942201 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)", "shortName": "SUBSEQUENT EVENTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "As_Of_6_30_2026_9ZwWnS3lqk-2T63TwyEkQQ", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "Unit_Standard_facility_veaUzXuB9EGCIUYLk78Akw", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2026_To_7_31_2026_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ohi_OperatorOfFourCareHomesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_lwa3vJJ4nU-1vOCXVbZggg", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "Unit_Standard_USD_1Qqthbp3qUaTB5eoAfU2JA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ohi-20260630x10q.htm", "unique": true } } }, "tag": { "stpr_AL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "AL", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Alabama" } } }, "auth_ref": [] }, "us-gaap_AboveMarketLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AboveMarketLeasesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Above market leases", "documentation": "Leases acquired as part of a real property acquisition at above market lease rate." } } }, "auth_ref": [ "r1220", "r1221", "r1222", "r1223", "r1224", "r1226", "r1227", "r1228" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]" } } }, "auth_ref": [] }, "ohi_AccountsAndNotesReceivableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AccountsAndNotesReceivableFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Accounts and notes receivable fair value disclosure.", "label": "Accounts And Notes Receivable Fair Value Disclosure", "terseLabel": "Non-real estate loans receivable - net" } } }, "auth_ref": [] }, "us-gaap_AccountsAndNotesReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsAndNotesReceivableNet", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 }, "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable Net Trade and Other", "terseLabel": "Non-real estate loans receivable - net", "totalLabel": "Non-real estate loans receivable - net", "documentation": "Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable." } } }, "auth_ref": [ "r1197", "r1341" ] }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsNotesAndLoansReceivableLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r315", "r1198" ] }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Receivable Type [Axis]", "documentation": "Information by type of receivable." } } }, "auth_ref": [ "r64", "r70" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued Expenses and Other Liabilities", "negatedLabel": "Accrued expenses and other liabilities", "terseLabel": "Accrued expenses and other liabilities", "verboseLabel": "Accrued expenses and other liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r109", "r110" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAndAccruedLiabilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities [Member]", "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_AccruedInvestmentIncomeReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedInvestmentIncomeReceivable", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Accrued investment income receivable", "documentation": "Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments." } } }, "auth_ref": [ "r106", "r733", "r1150" ] }, "us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedDistributionsInExcessOfNetIncomeMember", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Cumulative Dividends", "documentation": "Cumulative distributions to shareholders (or partners) in excess of retained earnings (or accumulated earnings)." } } }, "auth_ref": [] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r187", "r195", "r196", "r531", "r600", "r601", "r602", "r603", "r892", "r1162" ] }, "ohi_AccumulatedNetGainLossFromNetInvestmentHedgesAttributableToParentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AccumulatedNetGainLossFromNetInvestmentHedgesAttributableToParentMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as net investment hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Net Gain (Loss) from Net Investment Hedges Attributable to Parent [Member]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r194", "r195", "r600", "r601", "r602", "r603", "r638", "r640", "r641", "r642", "r643", "r644" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r17", "r18", "r73", "r184", "r729", "r761", "r762", "r1302" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r194", "r195", "r600", "r601", "r602", "r603", "r638", "r640", "r641", "r642", "r643", "r644" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r11", "r18", "r595", "r598", "r656", "r757", "r758", "r1162", "r1163", "r1164", "r1177", "r1178", "r1179", "r1180" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r2", "r11", "r18", "r71", "r72", "r195", "r196", "r640", "r641", "r642", "r643", "r644", "r1162" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r1076" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock - Additional Paid-In-Capital", "verboseLabel": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r65", "r1008", "r1375" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r775", "r1177", "r1178", "r1179", "r1180", "r1303", "r1378" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r1089" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r1089" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r1089" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r1089" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Stock related compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r458" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustment to reconcile net income to net cash provided by operating activities:" } } }, "auth_ref": [] }, "ohi_AdvancementsOnExistingNonRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AdvancementsOnExistingNonRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Advancements On Existing New Non Real Estate Loans [Member].", "label": "Advancements On Existing Non Real Estate Loans [Member]", "terseLabel": "Advances on existing non-real estate loans receivable" } } }, "auth_ref": [] }, "ohi_AdvancementsOnExistingRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AdvancementsOnExistingRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Advancements On Existing Real Estate Loans [Member].", "label": "Advancements On Existing Real Estate Loans [Member]", "terseLabel": "Advances on existing real estate loans receivable" } } }, "auth_ref": [] }, "ohi_AdvancementsOnNewNonRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AdvancementsOnNewNonRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Advancements On New Non Real Estate Loans [Member].", "label": "Advancements On New Non Real Estate Loans [Member]", "terseLabel": "Advances on new non-real estate loans receivable" } } }, "auth_ref": [] }, "ohi_AdvancementsOnNewRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AdvancementsOnNewRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Advancements On New Real Estate Loans [Member].", "label": "Advancements On New Real Estate Loans [Member]", "terseLabel": "Advances on new real estate loans receivable" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r1122" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1048", "r1058", "r1068", "r1100" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r1051", "r1061", "r1071", "r1103" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r1123" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r1089" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r1096" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1096", "r1104", "r1108", "r1116" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r1114" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Allocated Share-based Compensation Expense", "verboseLabel": "Stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r488", "r493", "r494" ] }, "ohi_AllowanceForCreditLossesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AllowanceForCreditLossesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Allowance For Credit Losses [Line Items]", "label": "Allowance For Credit Losses [Line Items]" } } }, "auth_ref": [] }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesTables" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of expected credit loss", "documentation": "Tabular disclosure of allowance for credit loss on financing receivable." } } }, "auth_ref": [ "r1204" ] }, "ohi_AllowanceForCreditLossesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AllowanceForCreditLossesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Allowance For Credit Losses [Table].", "label": "Allowance For Credit Losses [Table]" } } }, "auth_ref": [] }, "us-gaap_AllowanceForCreditLossesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllowanceForCreditLossesTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLosses" ], "lang": { "en-us": { "role": { "label": "Allowance for Credit Losses [Text Block]", "terseLabel": "ALLOWANCE FOR CREDIT LOSSES", "documentation": "The entire disclosure for allowance for credit losses." } } }, "auth_ref": [ "r35" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ohi_AmortizationOfDeferredFinancingAndRefinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AmortizationOfDeferredFinancingAndRefinancingCosts", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents amortization of deferred financing and refinancing costs.", "label": "Amortization Of Deferred Financing And Refinancing Costs", "verboseLabel": "Amortization of deferred financing costs and loss on debt extinguishment" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets." } } }, "auth_ref": [ "r8", "r206", "r348", "r354", "r886", "r893", "r894", "r896", "r898" ] }, "ohi_AmountOfAggregateDeferredRent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AmountOfAggregateDeferredRent", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "documentation": "The total aggregate amount of deferred rent.", "label": "Amount Of Aggregate Deferred Rent", "terseLabel": "Deferred rent, aggregate balance" } } }, "auth_ref": [] }, "ohi_AmountOfOtherCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AmountOfOtherCollateral", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of Other Collateral", "label": "Amount of Other Collateral", "negatedLabel": "Total collateral" } } }, "auth_ref": [] }, "us-gaap_AociAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AociAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r11", "r18", "r1162", "r1163", "r1164" ] }, "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r11", "r18", "r1162", "r1163", "r1164" ] }, "us-gaap_AssetAcquisitionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetAcquisitionTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsTables" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Table Text Block]", "terseLabel": "Summary of asset acquisitions", "documentation": "Tabular disclosure of asset acquisition." } } }, "auth_ref": [ "r1289" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r107", "r125", "r183", "r216", "r220", "r221", "r263", "r275", "r300", "r304", "r325", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r389", "r390", "r527", "r533", "r635", "r713", "r714", "r725", "r803", "r910", "r911", "r930", "r1008", "r1022", "r1023", "r1039", "r1243", "r1244", "r1329" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "totalLabel": "Total", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r609", "r610", "r1000" ] }, "ohi_AssetsHeldForSaleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AssetsHeldForSaleTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairments" ], "lang": { "en-us": { "role": { "documentation": "Entire disclosure for assets held for sale.", "label": "Assets Held For Sale [Text Block]", "verboseLabel": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS" } } }, "auth_ref": [] }, "ohi_AssetsSalesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AssetsSalesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Assets Sales [Line Items]", "label": "Assets Sales [Line Items]" } } }, "auth_ref": [] }, "ohi_AssetsSalesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AssetsSalesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Assets Sales [Table]", "label": "Assets Sales [Table]" } } }, "auth_ref": [] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsTotalMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Assets, Total [Member]", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [ "r1184" ] }, "ohi_AssistedLivingFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AssistedLivingFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents assisted living facilities.", "label": "Assisted Living Facilities [Member]" } } }, "auth_ref": [] }, "ohi_AtMarketOfferingProgramsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AtMarketOfferingProgramsLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "At The Market Offering Programs [Line Items].", "label": "At The Market Offering Programs [Line Items]" } } }, "auth_ref": [] }, "ohi_AtMarketOfferingProgramsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "AtMarketOfferingProgramsTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "At The Market Offering Programs [Table].", "label": "At The Market Offering Programs [Table]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r1111" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r1112" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r1107" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r1107" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r1107" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r1107" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r1107" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r1107" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r487" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r1110" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1109" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r1108" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r1108" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "documentation": "Information by location in statement of financial position where disaggregated cumulative balance is reported." } } }, "auth_ref": [ "r366", "r546", "r550", "r551", "r552", "r553", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r634", "r995", "r996", "r1131", "r1343" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Domain]", "documentation": "Location in statement of financial position where disaggregated cumulative balance is reported." } } }, "auth_ref": [ "r366", "r546", "r550", "r551", "r552", "r553", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r634", "r995", "r996", "r1131", "r1343" ] }, "ohi_BasisOfPresentationAndSignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Basis Of Presentation And Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "ohi_BasisOfPresentationAndSignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about basis of presentation and significant accounting policies.", "label": "Basis Of Presentation And Significant Accounting Policies [Table]" } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Basis Of Presentation and Significant Accounting Policies [Text Block]", "verboseLabel": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r1169" ] }, "us-gaap_BelowMarketLeaseAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BelowMarketLeaseAccumulatedAmortization", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails": { "parentTag": "us-gaap_BelowMarketLeaseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Below Market Lease, Accumulated Amortization", "negatedLabel": "Accumulated amortization", "documentation": "Amount of accumulated amortization of leases acquired as part of a real property acquisition at below market lease rate with a finite life." } } }, "auth_ref": [] }, "us-gaap_BelowMarketLeaseGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BelowMarketLeaseGross", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails": { "parentTag": "us-gaap_BelowMarketLeaseNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Below Market Lease, Gross", "verboseLabel": "Below market leases", "documentation": "Amount before amortization of leases acquired as part of a real property acquisition at below market lease rate with a finite life." } } }, "auth_ref": [] }, "us-gaap_BelowMarketLeaseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BelowMarketLeaseNet", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Below Market Lease, Net", "totalLabel": "Net intangible liabilities", "documentation": "Amount after amortization of leases acquired as part of a real property acquisition at below market lease rate with a finite life." } } }, "auth_ref": [] }, "ohi_BelowMarketLeaseWeightedAverageRemainingAmortizationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "BelowMarketLeaseWeightedAverageRemainingAmortizationPeriod", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents remaining amortization period of below market leases intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Below Market Lease Weighted Average Remaining Amortization Period", "verboseLabel": "Below market leases, weighted average remaining amortization, period" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Business Combination, Acquisition Related Costs", "negatedLabel": "Acquisition, merger and transition related costs", "terseLabel": "Acquisition, merger and transition related costs", "documentation": "Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department." } } }, "auth_ref": [ "r1286", "r1287" ] }, "country_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "CA", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails" ], "lang": { "en-us": { "role": { "label": "CANADA" } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying (Reported) Amount, Fair Value Disclosure [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r625", "r626", "r633", "r884", "r1319" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, At Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r27", "r179", "r887" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "totalLabel": "Cash, cash equivalents and restricted cash at end of period", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r27", "r87", "r215" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase in cash, cash equivalents and restricted cash", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r87" ] }, "us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Cash Flow Hedge Derivative Instrument Liabilities at Fair Value", "terseLabel": "Cash flow hedges recorded at fair value, liability", "documentation": "Fair value of all liability derivatives designated as cash flow hedging instruments." } } }, "auth_ref": [ "r1293", "r1294", "r1295" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [] }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashFlowSupplementalDisclosuresTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS", "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r82" ] }, "ohi_CertainEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "CertainEmployeesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Certain Employees [Member].", "label": "Certain Employees [Member]" } } }, "auth_ref": [] }, "ohi_CertainOfficersAndKeyEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "CertainOfficersAndKeyEmployeesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Certain Officers and Key Employees [Member].", "label": "Certain Officers and Key Employees [Member]" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r1087" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r1084" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r1082" ] }, "ohi_CienaHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "CienaHealthcareMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Information about Ciena Healthcare.", "label": "Ciena Healthcare [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1088" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r1088" ] }, "us-gaap_CollateralAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollateralAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Collateral [Axis]", "documentation": "Information by category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [ "r216", "r218", "r917", "r918", "r919", "r920", "r1017", "r1018" ] }, "us-gaap_CollateralDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollateralDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Collateral [Domain]", "documentation": "Category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [ "r216", "r218", "r917", "r918", "r919", "r920", "r1017", "r1018" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r93", "r369", "r370", "r867", "r1232", "r1237" ] }, "ohi_CommitmentsAndContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "CommitmentsAndContingenciesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Commitments And Contingencies [Line Items].", "label": "Commitments And Contingencies [Line Items]" } } }, "auth_ref": [] }, "ohi_CommitmentsAndContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "CommitmentsAndContingenciesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Commitments And Contingencies [Table].", "label": "Commitments And Contingencies [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquityParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Dividends, Per Share, Declared", "verboseLabel": "Dividend per Common Share", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r98" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock Par Value", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1026", "r1027", "r1028", "r1031", "r1032", "r1033", "r1036", "r1177", "r1178", "r1180", "r1303", "r1373", "r1378" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityNoncontrollingInterestDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock Par Or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r63" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r63", "r791" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock Shares Issued", "verboseLabel": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r63" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock Shares Outstanding", "verboseLabel": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r63", "r791", "r809", "r1378", "r1379" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 299,111 shares as of June 30, 2026 and 295,539 shares as of December 31, 2025", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r63", "r423", "r429", "r728", "r1008" ] }, "ohi_CommunicareHealthServicesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "CommunicareHealthServicesIncMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information regarding CommuniCare Health Services, Inc.", "label": "Communicare Health Services, Inc" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r1093" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r1092" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r1094" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r1091" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to common stockholders", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r19", "r191", "r193", "r200", "r711", "r739", "r740" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r50", "r101", "r191", "r193", "r199", "r710", "r739" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r267", "r312", "r766", "r767", "r866", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r267", "r312", "r766", "r767", "r866", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r267", "r312", "r766", "r767", "r866", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRisk" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Disclosure [Text Block]", "verboseLabel": "CONCENTRATION OF RISK", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r266", "r269", "r628", "r629", "r630", "r631", "r632", "r902", "r1183" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "verboseLabel": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r267", "r268", "r866", "r901", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration risk, percentage", "verboseLabel": "Concentration percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r267", "r312", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk." } } }, "auth_ref": [ "r267", "r268", "r866", "r901", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r267", "r312", "r766", "r767", "r866", "r1184", "r1185", "r1186", "r1187", "r1188" ] }, "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Condensed Financial Information of Parent Company Only Disclosure [Abstract]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r132", "r146", "r217", "r227", "r527", "r528", "r532", "r533", "r534", "r658", "r717", "r872", "r1141", "r1144", "r1145", "r1242", "r1245", "r1246" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r132", "r146", "r217", "r227", "r527", "r528", "r532", "r533", "r534", "r658", "r717", "r872", "r1141", "r1144", "r1145", "r1242", "r1245", "r1246" ] }, "srt_ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entity, Excluding Consolidated VIE [Member]", "documentation": "Consolidated entity excluding consolidated variable interest entity (VIE) for which reporting entity is primary beneficiary." } } }, "auth_ref": [] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r123", "r132", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r216", "r217", "r224", "r227", "r263", "r277", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r380", "r381", "r382", "r383", "r385", "r386", "r387", "r388", "r389", "r717", "r910", "r911", "r1142", "r1143", "r1243", "r1244" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r123", "r132", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r216", "r217", "r224", "r227", "r263", "r277", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r380", "r381", "r382", "r383", "r385", "r386", "r387", "r388", "r389", "r717", "r910", "r911", "r1142", "r1143", "r1243", "r1244" ] }, "ohi_ConstructionInProgressAndCapitalExpenditureInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ConstructionInProgressAndCapitalExpenditureInvestmentsTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of construction in progress and capital expenditure investments.", "label": "Construction In Progress And Capital Expenditure Investments [Table Text Block]", "terseLabel": "Summary of construction in progress and capital expenditure investments by segment" } } }, "auth_ref": [] }, "ohi_ContinuingCareRetirementCommunityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContinuingCareRetirementCommunityMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Continuing Care Retirement Community [Member].", "label": "Continuing Care Retirement Community [Member]", "terseLabel": "Continuing Care Retirement Community (CCRC)" } } }, "auth_ref": [] }, "us-gaap_ContractReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractReceivablesAbstract", "lang": { "en-us": { "role": { "label": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerAssetNet", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesScheduleOfNetAccountsReceivableDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Asset, Net", "terseLabel": "Contractual and other receivables - net", "verboseLabel": "Contractual receivables - net", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r446", "r447", "r448", "r452" ] }, "ohi_ContractualAndOtherReceivablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContractualAndOtherReceivablesNet", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 }, "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesScheduleOfNetAccountsReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesScheduleOfNetAccountsReceivableDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Contractual receivables and straight line receivables.", "label": "Contractual And Other Receivables Net", "terseLabel": "Other receivables and lease inducements", "totalLabel": "Contractual and other receivables - net", "verboseLabel": "Contractual and other receivables - net" } } }, "auth_ref": [] }, "us-gaap_ContractualObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractualObligation", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation", "terseLabel": "Remaining commitments", "verboseLabel": "Contractual obligation", "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments." } } }, "auth_ref": [ "r1171", "r1176", "r1337" ] }, "ohi_ContractualReceivablesAndOtherReceivablesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContractualReceivablesAndOtherReceivablesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "documentation": "Contractual Receivables And Other Receivables [Line Items]", "label": "Contractual Receivables And Other Receivables [Line Items]" } } }, "auth_ref": [] }, "ohi_ContractualReceivablesAndOtherReceivablesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContractualReceivablesAndOtherReceivablesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "documentation": "Contractual Receivables And Other Receivables [Table].", "label": "Contractual Receivables And Other Receivables [Table]" } } }, "auth_ref": [] }, "ohi_ContractualRentAndInterestPaymentsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContractualRentAndInterestPaymentsReceived", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails" ], "lang": { "en-us": { "role": { "documentation": "Contractual rent and interest payments received.", "label": "Contractual Rent and Interest Payments Received", "terseLabel": "Contractual rent and interest payments received" } } }, "auth_ref": [] }, "ohi_ContractualRentIncomeExpectedToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContractualRentIncomeExpectedToBeReceived", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Contractual rent income expected to be received.", "label": "Contractual Rent Income Expected to Be Received", "terseLabel": "Contractual rent income expected to be received" } } }, "auth_ref": [] }, "ohi_ContractualRentPaymentsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ContractualRentPaymentsReceived", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails" ], "lang": { "en-us": { "role": { "documentation": "Contractual rent payments received.", "label": "Contractual Rent Payments Received", "terseLabel": "Contractual rent payments received" } } }, "auth_ref": [] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "terseLabel": "Non-Segment/Corporate", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r14", "r299", "r300", "r301", "r302", "r305", "r1191" ] }, "us-gaap_CostOfPropertyRepairsAndMaintenance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfPropertyRepairsAndMaintenance", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Property Repairs and Maintenance", "terseLabel": "Repairs and maintenance", "documentation": "The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property." } } }, "auth_ref": [ "r77" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r166", "r167", "r216", "r225", "r226", "r395", "r434", "r657", "r667", "r721", "r889", "r890", "r891", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1298", "r1299", "r1300", "r1301" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CreditFacilityAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r379", "r1241" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CreditFacilityDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r379", "r1241" ] }, "us-gaap_CumulativeDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CumulativeDividends", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cumulative Dividends Paid", "negatedLabel": "Cumulative dividends paid", "documentation": "Amount of cumulative cash dividends distributed to shareholders." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r312", "r1185" ] }, "stpr_DC": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "DC", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "label": "DISTRICT OF COLUMBIA" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "BORROWING ARRANGEMENTS [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangements" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "verboseLabel": "BORROWING ARRANGEMENTS", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r94", "r216", "r219", "r361", "r362", "r363", "r364", "r365", "r378", "r379", "r391", "r397", "r398", "r399", "r400", "r401", "r402", "r407", "r414", "r415", "r417", "r592", "r646" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r16", "r53", "r54", "r108", "r111", "r392", "r393", "r394", "r395", "r396", "r398", "r403", "r404", "r405", "r406", "r408", "r409", "r410", "r411", "r412", "r413", "r925", "r926", "r927", "r928", "r929", "r1007", "r1170", "r1171", "r1172", "r1176", "r1233", "r1234", "r1235", "r1325", "r1326", "r1337" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "positiveLabel": "Long-term debt, gross", "verboseLabel": "Long-term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r16", "r111", "r418" ] }, "us-gaap_DebtInstrumentCovenantCompliance": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentCovenantCompliance", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Debt instrument, covenant compliance", "documentation": "States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure." } } }, "auth_ref": [ "r16", "r52" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "label": "Debt instrument, interest rate, stated percentage", "positiveLabel": "Rate", "positiveTerseLabel": "Interest rate", "terseLabel": "Interest rate", "verboseLabel": "Notes issued, interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r56", "r393" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r392", "r393", "r394", "r395", "r396", "r398", "r403", "r404", "r405", "r406", "r408", "r409", "r410", "r411", "r412", "r413", "r416", "r592", "r717", "r925", "r926", "r927", "r928", "r929", "r1007", "r1170", "r1171", "r1172", "r1176", "r1325", "r1326" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Maturity", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r57" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r16", "r392", "r393", "r394", "r395", "r396", "r398", "r403", "r404", "r405", "r406", "r408", "r409", "r410", "r411", "r412", "r413", "r925", "r926", "r927", "r928", "r929", "r1007", "r1170", "r1171", "r1172", "r1176", "r1233", "r1234", "r1235", "r1325", "r1326", "r1337" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule Of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r16", "r37", "r38", "r51", "r96", "r97", "r392", "r393", "r394", "r395", "r396", "r398", "r403", "r404", "r405", "r406", "r408", "r409", "r410", "r411", "r412", "r413", "r416", "r592", "r717", "r925", "r926", "r927", "r928", "r929", "r1007", "r1170", "r1171", "r1172", "r1176", "r1325", "r1326" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Discount - net", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1248", "r1324", "r1325", "r1326" ] }, "us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentVariableInterestRateTypeExtensibleEnumeration", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]", "documentation": "Indicates type of variable interest rate on debt instrument." } } }, "auth_ref": [ "r718" ] }, "us-gaap_DebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtWeightedAverageInterestRate", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Borrowings, weighted average interest rate", "documentation": "Weighted average interest rate of debt outstanding." } } }, "auth_ref": [] }, "us-gaap_DebtorInPossessionFinancingAmountArranged": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtorInPossessionFinancingAmountArranged", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "label": "Debtor-in-Possession Financing, Amount Arranged", "documentation": "Amount debtor-in-possession financing arranged (but not necessarily all borrowed)." } } }, "auth_ref": [ "r1328" ] }, "us-gaap_DebtorInPossessionFinancingBorrowingsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtorInPossessionFinancingBorrowingsOutstanding", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "label": "Debtor-in-Possession Financing, Borrowings Outstanding", "documentation": "Amount of debtor-in-possession borrowings outstanding." } } }, "auth_ref": [ "r1328" ] }, "ohi_DebtorInPossessionFinancingDefaultInterestRateOnBorrowingsOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DebtorInPossessionFinancingDefaultInterestRateOnBorrowingsOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Default interest rate on outstanding borrowings under debtor-in-possession financing arrangement.", "label": "Debtor-in-Possession Financing, Default Interest Rate on Borrowings Outstanding", "terseLabel": "Debtor-in-possession financing, default interest rate" } } }, "auth_ref": [] }, "us-gaap_DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "label": "Debtor-in-Possession Financing, Interest Rate on Borrowings Outstanding", "documentation": "Interest rate on outstanding borrowings under debtor-in-possession financing arrangement." } } }, "auth_ref": [ "r1328" ] }, "ohi_DeferredAggregateRent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DeferredAggregateRent", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of deferred aggregate rent.", "label": "Deferred aggregate rent" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "negatedLabel": "Deferred financing costs - net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1248", "r1324", "r1325", "r1326" ] }, "ohi_DeferredRentInterestPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DeferredRentInterestPercentage", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Deferred rent interest percentage.", "label": "Deferred Rent Interest Percentage", "terseLabel": "Deferred rent interest percentage" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "terseLabel": "Deferred tax assets, loss carryforwards", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1279" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net", "terseLabel": "Net deferred tax liability", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r1279" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "negatedLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r8", "r207", "r263", "r280", "r304", "r893", "r910", "r911" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r204", "r546", "r547", "r548", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r781", "r783", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r815", "r816", "r817", "r818", "r821", "r822", "r823", "r824", "r842", "r845", "r851", "r853", "r888", "r889", "r891", "r995", "r996", "r1026", "r1028", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1298", "r1299", "r1300", "r1301", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1314", "r1315" ] }, "us-gaap_DerivativeForwardExchangeRate1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeForwardExchangeRate1", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Forward Exchange Rate", "terseLabel": "Derivative, forward exchange rate", "documentation": "Contractual rate at which a foreign currency can be purchased or sold." } } }, "auth_ref": [] }, "ohi_DerivativeInstrumentNumberAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DerivativeInstrumentNumberAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information by number of derivative contract.", "label": "Derivative Instrument Number [Axis]" } } }, "auth_ref": [] }, "ohi_DerivativeInstrumentNumberDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DerivativeInstrumentNumberDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Information by number of derivative contract.", "label": "Derivative Instrument Number [Domain]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r204", "r546", "r547", "r548", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r781", "r783", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r815", "r816", "r817", "r818", "r821", "r822", "r823", "r824", "r842", "r845", "r851", "r853", "r888", "r889", "r891", "r995", "r996", "r1026", "r1028", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1298", "r1299", "r1300", "r1301", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1314", "r1315" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "DERIVATIVES AND HEDGING [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedging" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVES AND HEDGING", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r593", "r604", "r995", "r996", "r997", "r998", "r999" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r572", "r573", "r575", "r576", "r577", "r578", "r995" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [ "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r995" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value", "terseLabel": "Derivative instruments not designated, asset", "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset." } } }, "auth_ref": [ "r546", "r550", "r552", "r553", "r996" ] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "verboseLabel": "Derivative gain (loss), not designated as hedging instrument", "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments." } } }, "auth_ref": [ "r204", "r561", "r996" ] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value", "terseLabel": "Derivative instruments not designated, liabilities", "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability." } } }, "auth_ref": [ "r550", "r552", "r553", "r996" ] }, "us-gaap_DerivativeMaturityDates": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeMaturityDates", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, maturity Date", "documentation": "Date derivative contract ends, in YYYY-MM-DD format." } } }, "auth_ref": [ "r782", "r783", "r842", "r844", "r847", "r850", "r852", "r1028" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, notional amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r995", "r1290", "r1291" ] }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeNumberOfInstrumentsHeld", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Number of Instruments Held", "terseLabel": "Number of Instruments Held, derivative", "documentation": "The number of derivative instruments of a particular group held by the entity." } } }, "auth_ref": [ "r782", "r842", "r843", "r846", "r1028", "r1290", "r1291" ] }, "us-gaap_DerivativeVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeVariableInterestRate", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Variable Interest Rate", "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DevelopmentInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DevelopmentInProcess", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Development in Process", "terseLabel": "Construction in progress", "documentation": "The current amount of expenditures for a real estate project that has not yet been completed." } } }, "auth_ref": [ "r1338", "r1339" ] }, "us-gaap_DirectFinancingLeaseInterestIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DirectFinancingLeaseInterestIncome", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails": { "parentTag": "us-gaap_LeaseIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Interest Income", "terseLabel": "Interest income from direct financing leases", "documentation": "Amount of interest income from net investment in direct financing lease." } } }, "auth_ref": [ "r264", "r653" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss, Excluding Accrued Interest", "periodEndLabel": "Direct Financing Lease, ending balance", "periodStartLabel": "Direct Financing Lease, beginning balance", "documentation": "Amount excluding accrued interest, of allowance for credit loss on net investment in direct financing lease." } } }, "auth_ref": [ "r1203" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossPeriodIncreaseDecrease", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Direct financing receivable allowance, increase (decrease)", "documentation": "Amount of increase (decrease) in allowance for credit loss on net investment in direct financing lease." } } }, "auth_ref": [ "r1204" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossRollForward", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "DirectorMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Directors", "documentation": "Person serving on board of directors." } } }, "auth_ref": [ "r1146", "r1196", "r1374" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "verboseLabel": "STOCK-BASED COMPENSATION", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r456", "r460", "r489", "r490", "r491", "r937" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Stock-Based Compensation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfLongLivedAssetsHeldForSaleTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of Long Lived Assets Held-for-sale [Table Text Block]", "verboseLabel": "Schedule of Properties Held-for-Sale", "documentation": "Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss)." } } }, "auth_ref": [ "r13" ] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]", "terseLabel": "Summary of stock-based compensation expense", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r1251" ] }, "ohi_DistributionsToOpUnitHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DistributionsToOpUnitHolders", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Distributions to OP Unit Holders.", "label": "Distributions to OP Unit Holders", "negatedLabel": "Distributions to Omega OP Unit Holders" } } }, "auth_ref": [] }, "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendPayableDateToBePaidDayMonthAndYear", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Payable, Date to be Paid", "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r29" ] }, "ohi_DividendReinvestmentAndCommonStockPurchasePlanLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DividendReinvestmentAndCommonStockPurchasePlanLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "documentation": "Dividend Reinvestment And Common Stock Purchase Plan [Line Items].", "label": "Dividend Reinvestment And Common Stock Purchase Plan [Line Items]" } } }, "auth_ref": [] }, "ohi_DividendReinvestmentAndCommonStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DividendReinvestmentAndCommonStockPurchasePlanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information regarding dividend reinvestment and common stock purchase plan.", "label": "Dividend Reinvestment And Common Stock Purchase Plan [Member]" } } }, "auth_ref": [] }, "ohi_DividendReinvestmentAndCommonStockPurchasePlanTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "DividendReinvestmentAndCommonStockPurchasePlanTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "documentation": "Dividend Reinvestment And Common Stock Purchase Plan [Table].", "label": "Dividend Reinvestment And Common Stock Purchase Plan [Table]" } } }, "auth_ref": [] }, "us-gaap_DividendsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends [Axis]", "documentation": "Information by event wherein earnings are distributed to shareholder." } } }, "auth_ref": [ "r1249", "r1250" ] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Dividends Common Stock", "negatedLabel": "Common dividends declared", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r4", "r98" ] }, "us-gaap_DividendsDeclaredTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsDeclaredTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Dividends Declared [Table Text Block]", "terseLabel": "Schedule of common stock dividends", "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends." } } }, "auth_ref": [] }, "us-gaap_DividendsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends [Domain]", "documentation": "Event wherein earnings are distributed to shareholder." } } }, "auth_ref": [ "r1249", "r1250" ] }, "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsPayableDateOfRecordDayMonthAndYear", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Declared, Date Of Record", "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsPayableLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Payable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsPayableTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Payable [Table]", "documentation": "Disclosure of information about distribution of earnings to shareholder declared but not yet paid. Includes, but is not limited to, total amount and amount per share of distribution, declaration date, and date to be paid." } } }, "auth_ref": [ "r29" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r1043" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1075" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r1086" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings per Share [Abstract]", "verboseLabel": "Earnings per common share available to common stockholders:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic Net (Loss) Income (In Dollars Per Share)", "verboseLabel": "Net income available to common stockholders", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r174", "r201", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r246", "r249", "r256", "r257", "r258", "r262", "r421", "r492", "r518", "r525", "r607", "r608", "r712", "r741", "r900" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings per share - basic:", "verboseLabel": "Basic:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted Net (Loss) Income (In Dollars Per Share)", "verboseLabel": "Net income available to common stockholders", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r174", "r201", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r249", "r256", "r257", "r258", "r262", "r421", "r492", "r518", "r525", "r607", "r608", "r712", "r741", "r900" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings per share - diluted:", "verboseLabel": "Diluted:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted, Other Disclosures [Abstract]", "verboseLabel": "Effect of dilutive securities:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "verboseLabel": "EARNINGS PER SHARE", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r245", "r259", "r260", "r261" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "verboseLabel": "Effect of foreign currency translation on cash, cash equivalents and restricted cash", "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r637" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277" ] }, "us-gaap_EmploymentContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmploymentContractsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Employment Contracts [Member]", "documentation": "Contracts securing the services of employees, which may define the period of employment and the nature of the business relationship, and which may include nondisclosure and noncompete restrictions." } } }, "auth_ref": [ "r964", "r1220", "r1221", "r1222", "r1223", "r1224", "r1226", "r1227", "r1228" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1041" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1041" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1041" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1125" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1041" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1041" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1041" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1041" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r1080" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r1121" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r1121" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r1121" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r171", "r173", "r174", "r194", "r195", "r196", "r228", "r229", "r230", "r232", "r239", "r241", "r243", "r265", "r327", "r328", "r359", "r420", "r445", "r492", "r507", "r508", "r515", "r516", "r517", "r519", "r524", "r525", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r606", "r638", "r640", "r641", "r642", "r643", "r644", "r647", "r649", "r656", "r738", "r757", "r758", "r759", "r775", "r827" ] }, "ohi_EquityDistributionAgreementGrossSalesPriceMaximum": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "EquityDistributionAgreementGrossSalesPriceMaximum", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum aggregate gross sales price of shares to be sold in an equity distribution agreement.", "label": "Equity Distribution Agreement Gross Sales Price Maximum", "terseLabel": "Sales price, equity distribution agreement" } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r321", "r322", "r324", "r514", "r635", "r1127", "r1128", "r1129", "r1282", "r1283", "r1284", "r1285" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfReconciliationOfGoodwillDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership %", "verboseLabel": "Percentage of ownership interest", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r321", "r635" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "ohi_TotalRealEstateInvestments", "weight": 1.0, "order": 3.0 }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments", "terseLabel": "Investments in unconsolidated entities", "verboseLabel": "Investment in unconsolidated joint venture", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r263", "r285", "r304", "r319", "r1148", "r1201" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "INVESTMENTS IN UNCONSOLIDATED ENTITIES [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityMethodInvestmentsDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntities" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "verboseLabel": "INVESTMENTS IN UNCONSOLIDATED ENTITIES", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group." } } }, "auth_ref": [ "r131", "r323", "r326", "r1129" ] }, "us-gaap_EquityMethodInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityMethodInvestmentsTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesTables" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Schedule of equity method investments", "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information." } } }, "auth_ref": [ "r320" ] }, "ohi_EquityShelfProgram1.0BillionAnd1.25BillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "EquityShelfProgram1.0BillionAnd1.25BillionMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Equity Shelf Program 1.0 Billion and $1.25 Billion [Member].", "label": "Equity Shelf Program 1.0 Billion and $1.25 Billion [Member]" } } }, "auth_ref": [] }, "ohi_EquityShelfProgram1.25BillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "EquityShelfProgram1.25BillionMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Equity Shelf Program $1.25 Billion [Member].", "label": "Equity Shelf Program 1.25 Billion [Member]", "terseLabel": "$1.25 Billion ATM Program" } } }, "auth_ref": [] }, "ohi_EquityShelfProgram2BillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "EquityShelfProgram2BillionMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Equity Shelf Program 2 Billion [Member].", "label": "Equity Shelf Program 2 Billion [Member]", "terseLabel": "$2.0 Billion ATM Program" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r1090" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r1048", "r1058", "r1068", "r1100" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r1045", "r1055", "r1065", "r1097" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Estimate Of Fair Value, Fair Value Disclosure [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r405", "r623", "r625", "r633", "r884", "r926", "r927" ] }, "ohi_ExchangeAccommodationTitleholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ExchangeAccommodationTitleholdersMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Exchange Accommodation Titleholders [Member].", "label": "Exchange Accommodation Titleholders [Member]" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r1096" ] }, "ohi_ExistingTwoNonRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ExistingTwoNonRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Existing Two Non Real Estate Loans [Member].", "label": "Existing Two Non Real Estate Loans [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesAcquiredAcquisitionCompletedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesAcquiredAcquisitionCompletedMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Acquired Acquisition Completed [Member].", "label": "Facilities Acquired Acquisition Completed [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesAcquiredAcquisitionPendingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesAcquiredAcquisitionPendingMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Acquired Acquisition Pending [Member].", "label": "Facilities Acquired Acquisition Pending [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesAcquiredMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesAcquiredMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Acquired [Member].", "label": "Facilities Acquired" } } }, "auth_ref": [] }, "ohi_FacilitiesBeingTransitionedToOtherOperatorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesBeingTransitionedToOtherOperatorMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Being Transitioned to Other Operator [Member].", "label": "Facilities Being Transitioned To Other Operator [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesClassifiedToAssetHeldForSaleMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesClassifiedToAssetHeldForSaleMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Classified to Asset Held for Sale [Member].", "label": "Facilities Classified to Asset Held for Sale [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesLeasedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesLeasedMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Leased [Member].", "label": "Facilities Leased" } } }, "auth_ref": [] }, "ohi_FacilitiesSoldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesSoldMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Sold [Member].", "label": "Facilities Sold" } } }, "auth_ref": [] }, "ohi_FacilitiesSoldPendingUnder1031ExchangeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesSoldPendingUnder1031ExchangeMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Sold Pending Under 1031 Exchange [Member].", "label": "Facilities Sold Pending Under 1031 Exchange [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesSubjectToMasterLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesSubjectToMasterLeaseMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Subject to Master Lease [Member].", "label": "Facilities Subject to Master Lease [Member]", "terseLabel": "Facilities Subject to Master Lease" } } }, "auth_ref": [] }, "ohi_FacilitiesTransitionedFromOperatorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesTransitionedFromOperatorsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Transitioned From Operators [Member].", "label": "Facilities Transitioned From Operators [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesTransitionedToOtherOperatorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesTransitionedToOtherOperatorsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Transitioned to Other Operators [Member].", "label": "Facilities Transitioned to Other Operators [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesUnderFixedRateMortgageLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesUnderFixedRateMortgageLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities Under Fixed Rate Mortgage Loans [Member].", "label": "Facilities Under Fixed Rate Mortgage Loans [Member]" } } }, "auth_ref": [] }, "ohi_FacilitiesWithImpairmentChargesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FacilitiesWithImpairmentChargesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Facilities With Impairment Charges [Member].", "label": "Facilities With Impairment Charges [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "verboseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r623", "r625", "r626", "r884", "r1006", "r1319" ] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, By Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r623", "r626", "r884", "r1006", "r1317", "r1319" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, By Balance Sheet Grouping [Table Text Block]", "verboseLabel": "Schedule of Financial Instruments", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r624", "r627", "r884", "r1006", "r1319" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r405", "r623", "r625", "r626", "r633", "r635", "r636", "r884", "r926", "r927", "r1319" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Financial Instruments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "FINANCIAL INSTRUMENTS", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r611", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r706", "r1000", "r1003" ] }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Federal Income Tax Expense (Benefit), Continuing Operations", "terseLabel": "Federal income tax (benefit) expense", "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r216", "r222", "r497", "r498" ] }, "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]", "verboseLabel": "Assets:" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]", "verboseLabel": "Liabilities:" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": -1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsAndNotesReceivableNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Financing receivable, allowance for credit losses", "negatedLabel": "Allowance for credit losses", "periodEndLabel": "CECL Ending balance", "periodStartLabel": "CECL Beginning balance", "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r1203" ] }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableAllowanceForCreditLossesRollForward", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableBeforeAllowanceForCreditLossByOriginationYearAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableBeforeAllowanceForCreditLossByOriginationYearAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesTables" ], "lang": { "en-us": { "role": { "label": "Financing Receivable Credit Quality Indicators [Table Text Block]", "terseLabel": "Schedule by segment balance by vintage and credit quality indicator", "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics." } } }, "auth_ref": [ "r1205" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "ohi_TotalRealEstateInvestments", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loans Receivable, Net", "terseLabel": "Real estate loans receivable - net", "totalLabel": "Real estate loans receivable - net", "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r1203" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": "ohi_TotalReceivableAllowanceForCreditLossWriteoff", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-offs charged against allowance for the period ended", "terseLabel": "Write-offs of Financing Receivable Charged Against Allowance", "documentation": "Amount, excluding accrued interest, of decrease in allowance for credit loss on financing receivable from writeoff. Excludes net investment in lease." } } }, "auth_ref": [ "r331", "r335" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails": { "parentTag": "us-gaap_AccountsAndNotesReceivableNet", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalReceivableBeforeAllowanceForCreditLossTotal", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss", "positiveLabel": "Financing receivable, gross", "terseLabel": "Financing receivable, gross", "totalLabel": "Total Balance", "verboseLabel": "Financing receivable, gross", "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r333", "r334", "r1203" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": "ohi_TotalReceivableCreditLossExpenseReversal", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "terseLabel": "Provision (Recovery) for Credit Losses", "verboseLabel": "Additional reserve (recovery) through provision for credit losses", "documentation": "Amount, excluding accrued interest, of credit loss expense (reversal of expense) on financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r205", "r330" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestRevolving": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestRevolving", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Revolving", "verboseLabel": "Revolving Loans", "documentation": "Amortized cost excluding accrued interest, of financing receivable that can be withdrawn, repaid, and redrawn." } } }, "auth_ref": [ "r333", "r335", "r922" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Originated Four Years before Latest Fiscal Year", "terseLabel": "2022", "documentation": "Amortized cost excluding accrued interest, of financing receivable originated four years prior to current fiscal year. Excludes net investment in lease." } } }, "auth_ref": [ "r333", "r335", "r922" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Originated Three Years before Latest Fiscal Year", "terseLabel": "2023", "documentation": "Amortized cost excluding accrued interest, of financing receivable originated three years prior to current fiscal year. Excludes net investment in lease." } } }, "auth_ref": [ "r333", "r335", "r922" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalReceivableYearOneOriginatedCurrentFiscalYear", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Originated in Current Fiscal Year", "terseLabel": "2026", "documentation": "Amortized cost excluding accrued interest, of financing receivable originated in current fiscal year. Excludes net investment in lease." } } }, "auth_ref": [ "r333", "r335", "r922" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Originated Two Years before Latest Fiscal Year", "terseLabel": "2024", "documentation": "Amortized cost excluding accrued interest, of financing receivable originated two years prior to current fiscal year. Excludes net investment in lease." } } }, "auth_ref": [ "r333", "r335", "r922" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Originated in Fiscal Year before Latest Fiscal Year", "terseLabel": "2025", "documentation": "Amortized cost excluding accrued interest of financing receivable originated in fiscal year prior to current fiscal year. Excludes net investment in lease." } } }, "auth_ref": [ "r333", "r335", "r922" ] }, "ohi_FinancingReceivableFairValueOfCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivableFairValueOfCollateral", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable fair value of collateral.", "label": "Financing Receivable Fair Value of Collateral", "terseLabel": "Fair value of collateral" } } }, "auth_ref": [] }, "ohi_FinancingReceivableInterestPaymentsAppliedAgainstPrincipalForCostRecoveryLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivableInterestPaymentsAppliedAgainstPrincipalForCostRecoveryLoans", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of interest payments applied against principal for cost recovery loans.", "label": "Financing Receivable, Interest Payments Applied Against Principal for Cost Recovery Loans", "terseLabel": "Interest payments applied against principal for cost recovery loans" } } }, "auth_ref": [] }, "ohi_FinancingReceivableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivableInterestRate", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable interest rate.", "label": "Financing Receivable Interest Rate", "terseLabel": "Interest rate" } } }, "auth_ref": [] }, "ohi_FinancingReceivableLoanPercentageOfAllFinancingReceivables": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivableLoanPercentageOfAllFinancingReceivables", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable, loan percentage of all financing receivables.", "label": "Financing Receivable, Loan Percentage Of All Financing Receivables", "terseLabel": "Financing receivable, loan percentage of all financing receivables" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableNonaccrualInterestIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivableNonaccrualInterestIncome", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Nonaccrual, Interest Income", "terseLabel": "Interest income related to loans on non-accrual status", "documentation": "Amount of interest income on financing receivable on nonaccrual status." } } }, "auth_ref": [ "r332" ] }, "ohi_FinancingReceivableOriginatedFiveYearsBeforeLatestFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivableOriginatedFiveYearsBeforeLatestFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of financing receivable originated five years prior to latest fiscal year.", "label": "Financing Receivable Originated Five Years Before Latest Fiscal Year", "terseLabel": "2021" } } }, "auth_ref": [] }, "ohi_FinancingReceivableOriginatedSixOrMoreYearsBeforeLatestFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivableOriginatedSixOrMoreYearsBeforeLatestFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable originated six or more years before latest fiscal year.", "label": "Financing Receivable Originated Six Or More Years Before Latest Fiscal Year", "terseLabel": "2020 & older" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivablePracticalExpedientAccruedInterestExclusion": { "xbrltype": "booleanItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivablePracticalExpedientAccruedInterestExclusion", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Practical Expedient, Accrued Interest Exclusion [true false]", "documentation": "Indicates (true false) whether practical expedient was elected to exclude accrued interest from financing receivable." } } }, "auth_ref": [ "r333" ] }, "ohi_FinancingReceivablePrincipalPaymentsReceivedAgainstFullyReservedAmounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FinancingReceivablePrincipalPaymentsReceivedAgainstFullyReservedAmounts", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Financing receivable, principal payments received against fully reserved amounts.", "label": "Financing Receivable, Principal Payments Received Against Fully Reserved Amounts", "terseLabel": "Financing receivable, principal payments received against fully reserved amounts" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingReceivablesTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivable" ], "lang": { "en-us": { "role": { "label": "Financing Receivables [Text Block]", "verboseLabel": "REAL ESTATE LOANS RECEIVABLE", "documentation": "The entire disclosure for financing receivable." } } }, "auth_ref": [ "r313", "r316", "r317", "r318", "r916" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r181", "r336", "r353", "r886" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Amortization expense, 2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r355", "r882", "r886" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Amortization expense, remaining 2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [ "r1388" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Amortization expense, 2030", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r355", "r882", "r886" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Amortization expense, 2029", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r355", "r882", "r886" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Amortization expense, 2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r355", "r882", "r886" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r347", "r349", "r350", "r351", "r352", "r353", "r356", "r357", "r670", "r671", "r765", "r882", "r886", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965", "r966", "r967", "r968", "r969", "r970", "r971" ] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Gross intangible assets", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r336", "r353", "r671", "r886" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r347", "r349", "r350", "r351", "r352", "r353", "r356", "r357", "r765", "r882", "r886", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965", "r966", "r967", "r968", "r969", "r970", "r971" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Net intangible assets", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r670", "r1226" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "verboseLabel": "Assets:" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "verboseLabel": "Weighted average remaining amortization", "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r670" ] }, "ohi_FiniteLivedIntangibleLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FiniteLivedIntangibleLiabilitiesNetAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Liabilities Net Abstract", "verboseLabel": "Liabilities:" } } }, "auth_ref": [] }, "us-gaap_FixturesAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FixturesAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Fixtures and Equipment, Gross", "terseLabel": "Furniture and equipment", "documentation": "Amount before accumulated depreciation of fixtures and equipment. Includes, but is not limited to, machinery, equipment, and engines." } } }, "auth_ref": [] }, "ohi_FoodExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FoodExpense", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of food related expenses incurred.", "label": "Food Expense", "terseLabel": "Food" } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r891", "r934", "r935", "r977", "r978", "r983", "r984", "r985", "r986", "r987", "r991", "r992", "r993", "r994", "r996", "r1000", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1160", "r1161", "r1298" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r797", "r801", "r806", "r817", "r823", "r848", "r849", "r851", "r976", "r980", "r981", "r982", "r988", "r989", "r990", "r1028", "r1297" ] }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Income Tax Expense (Benefit), Continuing Operations", "verboseLabel": "Foreign tax expense", "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations." } } }, "auth_ref": [ "r216", "r222", "r498" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1104" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1104" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1104" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1104" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1104" ] }, "ohi_FourFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FourFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Four Facilities [Member].", "label": "4 Facilities" } } }, "auth_ref": [] }, "ohi_FourNewNonRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FourNewNonRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Four New Non Real Estate Loans [Member].", "label": "Four New Non Real Estate Loans [Member]" } } }, "auth_ref": [] }, "ohi_FourOfThirtyFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FourOfThirtyFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Four of Thirty Facilities [Member].", "label": "Four of Thirty Facilities [Member]", "terseLabel": "4 of 30 Facilities" } } }, "auth_ref": [] }, "ohi_FourOfTwentySixFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FourOfTwentySixFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Four of Twenty Six Facilities [Member].", "label": "Four of Twenty Six Facilities [Member]", "terseLabel": "4 of 26 Facilities" } } }, "auth_ref": [] }, "ohi_FourteenNewRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "FourteenNewRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Fourteen New Real Estate Loans [Member].", "label": "Fourteen New Real Estate Loans [Member]" } } }, "auth_ref": [] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r1085" ] }, "stpr_GA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "GA", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Georgia" } } }, "auth_ref": [] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "GB", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "United Kingdom" } } }, "auth_ref": [] }, "ohi_GainLossInEquityMethodInvestmentOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GainLossInEquityMethodInvestmentOperatingActivities", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Gain (Loss) in equity method investment operating activities.", "label": "Gain Loss In Equity Method Investment Operating Activities", "terseLabel": "Loss from unconsolidated entities" } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainLossOnDispositionOfAssets", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Gain (loss) on assets sold - net", "terseLabel": "Amount of gain (loss) from sale of facilities", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property." } } }, "auth_ref": [ "r1168", "r1229", "r1231" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Gain on assets sold - net", "verboseLabel": "Gain on assets sold - net", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r1168" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and Administrative", "negatedLabel": "General and administrative", "terseLabel": "General and administrative", "verboseLabel": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r79", "r812" ] }, "ohi_GenesisHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GenesisHealthcareMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information about one of the borrower.", "label": "Genesis Healthcare [Member]" } } }, "auth_ref": [] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Geographic Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r866", "r1188" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfReconciliationOfGoodwillDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Goodwill", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "verboseLabel": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r180", "r337", "r707", "r911", "r923", "r940", "r941", "r942", "r973", "r1001", "r1008", "r1209", "r1216", "r1288" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Other Intangibles [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangibles" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "GOODWILL AND OTHER INTANGIBLES", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r1207", "r1219" ] }, "ohi_GoodwillAndOtherIntangiblesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GoodwillAndOtherIntangiblesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Goodwill And Other Intangibles [Line Items].", "label": "Goodwill And Other Intangibles [Line Items]" } } }, "auth_ref": [] }, "ohi_GoodwillAndOtherIntangiblesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GoodwillAndOtherIntangiblesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Goodwill And Other Intangibles [Table].", "label": "Goodwill And Other Intangibles [Table]" } } }, "auth_ref": [] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfReconciliationOfGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency translation", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r344", "r523" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillRollForward", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesScheduleOfReconciliationOfGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ohi_GrossProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GrossProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The gross cash inflow from the additional capital contribution to the entity.", "label": "Gross Proceeds from Issuance of Common Stock", "terseLabel": "Gross proceeds" } } }, "auth_ref": [] }, "ohi_GrossProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GrossProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "The gross amount from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Gross Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Gross proceeds received from sale" } } }, "auth_ref": [] }, "ohi_GroundLeaseExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "GroundLeaseExpensesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Ground Lease Expenses [Member].", "label": "Ground Lease Expenses [Member]" } } }, "auth_ref": [] }, "us-gaap_GuaranteeObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GuaranteeObligationsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Guarantee Obligations [Member]", "documentation": "A written or oral contract that obligates the guarantor to either pay cash or perform services if another party fails to perform specified actions or achieve specified results." } } }, "auth_ref": [] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [] }, "stpr_IN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "IN", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Indiana" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfRealEstate", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Impairment of Real Estate", "negatedLabel": "Impairment on real estate properties", "positiveTerseLabel": "Impairment on real estate properties", "verboseLabel": "Impairment on real estate properties", "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value." } } }, "auth_ref": [ "r1168", "r1230" ] }, "ohi_InSubstanceRealEstateInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InSubstanceRealEstateInvestmentMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "In Substance Real Estate Investment [Member].", "label": "In Substance Real Estate Investment [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest", "totalLabel": "Income before income tax expense and income (loss) from unconsolidated entities", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r124", "r742", "r904", "r1022", "r1023", "r1182", "r1190", "r1192", "r1193", "r1194" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Income (loss) from unconsolidated entities", "verboseLabel": "Income (loss) from unconsolidated joint ventures", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r8", "r75", "r115", "r263", "r282", "r304", "r319", "r734" ] }, "ohi_IncomeLossNonControllingInterestAndParticipatingShareAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "IncomeLossNonControllingInterestAndParticipatingShareAdjustments", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Income (loss) non controlling interest and participating share adjustments.", "label": "Income Loss Non Controlling Interest And Participating Share Adjustments", "negatedLabel": "Less: adjustments to basic numerator" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "ohi_IncomeStatementLineItemDisaggregationAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "IncomeStatementLineItemDisaggregationAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Income Statement Line Item Disaggregation [Axis]", "label": "Income Statement Line Item Disaggregation [Axis]" } } }, "auth_ref": [] }, "ohi_IncomeStatementLineItemDisaggregationDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "IncomeStatementLineItemDisaggregationDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Income Statement Line Item Disaggregation [Domain]", "label": "Income Statement Line Item Disaggregation [Domain]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Taxes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "TAXES", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r216", "r223", "r496", "r499", "r500", "r501", "r502", "r503", "r504", "r509", "r511", "r512", "r513", "r719", "r764", "r772", "r939" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense", "totalLabel": "Total income tax expense", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r129", "r130", "r216", "r242", "r243", "r263", "r283", "r304", "r497", "r499", "r510", "r743", "r895", "r897", "r899", "r939" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid, Net", "terseLabel": "Taxes paid during the period", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r28", "r214", "r505", "r506" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Contract Receivables, Net", "negatedLabel": "Contractual receivables", "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r1167" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "verboseLabel": "Change in operating assets and liabilities - net:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Other Operating Capital Net", "negatedLabel": "Other operating assets and liabilities", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquityParentheticals" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) In Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ohi_IncreaseDecreaseInStraightLineReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "IncreaseDecreaseInStraightLineReceivables", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due that is the result of the cumulative difference between actual amount due and the adjustment needed to recognize income on a straight-line basis.", "label": "Increase Decrease In Straight Line Receivables", "negatedLabel": "Straight-line receivables" } } }, "auth_ref": [] }, "ohi_IndemnificationAgreementOccurrencePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "IndemnificationAgreementOccurrencePeriod", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Indemnification agreement occurrence period.", "label": "Indemnification Agreement Occurrence Period", "terseLabel": "Indemnification agreement occurrence period" } } }, "auth_ref": [] }, "us-gaap_IndemnificationGuaranteeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndemnificationGuaranteeMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Indemnification Agreement [Member]", "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor." } } }, "auth_ref": [ "r1240" ] }, "ohi_IndependentLivingFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "IndependentLivingFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Independent Living Facilities [Member].", "label": "Independent Living Facilities [Member]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1096", "r1104", "r1108", "r1116" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r1114" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r1044", "r1120" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r1044", "r1120" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r1044", "r1120" ] }, "us-gaap_InterestAndFeeIncomeLoansAndLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestAndFeeIncomeLoansAndLeases", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Mortgage Interest Income", "terseLabel": "Interest income", "verboseLabel": "Interest income", "documentation": "The aggregate interest and fee income generated by: (1) loans the Entity has positive intent and ability to hold for the foreseeable future, or until maturity or payoff, including commercial and consumer loans, whether domestic or foreign, which may consist of: (a) industrial and agricultural; (b) real estate; and (c) real estate construction loans; (d) trade financing; (e) lease financing; (f) home equity lines-of-credit; (g) automobile and other vehicle loans; and (h) credit card and other revolving-type loans and (2) loans and leases held-for-sale which may include mortgage loans, direct financing, and sales-type leases." } } }, "auth_ref": [ "r114", "r897" ] }, "us-gaap_InterestAndOtherIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestAndOtherIncomeTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Interest and Other Income [Table Text Block]", "terseLabel": "Summary of Real Estate interest income", "documentation": "Tabular disclosure of interest income and income classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 4.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest expense", "negatedLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r80", "r411", "r419", "r928", "r929", "r1377" ] }, "ohi_InterestPaidInCash": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InterestPaidInCash", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Interest paid in cash.", "label": "Interest Paid In Cash" } } }, "auth_ref": [] }, "ohi_InterestPaidInKind": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InterestPaidInKind", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Interest paid in kind.", "label": "Interest Paid In Kind" } } }, "auth_ref": [] }, "ohi_InterestPaidInKindOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InterestPaidInKindOperatingActivities", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Interest paid in kind operating activities.", "label": "Interest Paid In Kind Operating Activities", "terseLabel": "Interest paid-in-kind" } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Net", "verboseLabel": "Interest paid during the period, net of amounts capitalized", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r208", "r212", "r213" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestRateContractMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r883", "r891", "r934", "r935", "r976", "r977", "r978", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r996", "r1000", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1160", "r1161", "r1298" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestRateSwapMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Interest Rate Swap", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r995", "r1034", "r1035", "r1296" ] }, "us-gaap_InternalCreditAssessmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InternalCreditAssessmentAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Internal Credit Assessment [Axis]", "documentation": "Information by entity-defined rating." } } }, "auth_ref": [ "r126", "r127", "r128", "r921", "r922", "r1206" ] }, "us-gaap_InternalCreditAssessmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InternalCreditAssessmentDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Internal Credit Assessment [Domain]", "documentation": "Entity defined credit risk rating." } } }, "auth_ref": [ "r921", "r1206" ] }, "ohi_InternalCreditRatingFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InternalCreditRatingFiveMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Internal Credit Rating Five [Member].", "label": "Internal Credit Rating Five [Member]" } } }, "auth_ref": [] }, "ohi_InternalCreditRatingFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InternalCreditRatingFourMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Internal Credit Rating Four [Member].", "label": "Internal Credit Rating Four [Member]" } } }, "auth_ref": [] }, "ohi_InternalCreditRatingOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InternalCreditRatingOneMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Internal Credit Rating One [Member].", "label": "Internal Credit Rating One [Member]" } } }, "auth_ref": [] }, "ohi_InternalCreditRatingSixMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InternalCreditRatingSixMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Internal Credit Rating Six [Member].", "label": "Internal Credit Rating Six [Member]" } } }, "auth_ref": [] }, "ohi_InternalCreditRatingThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InternalCreditRatingThreeMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Internal Credit Rating Three [Member].", "label": "Internal Credit Rating Three [Member]" } } }, "auth_ref": [] }, "ohi_InternalCreditRatingTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InternalCreditRatingTwoMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Internal Credit Rating Two [Member].", "label": "Internal Credit Rating Two [Member]" } } }, "auth_ref": [] }, "us-gaap_InvestmentBuildingAndBuildingImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentBuildingAndBuildingImprovements", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investment Building and Building Improvements", "terseLabel": "Buildings and improvements", "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements." } } }, "auth_ref": [ "r1338", "r1339" ] }, "ohi_InvestmentCharacteristicTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentCharacteristicTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "Information related to investment characteristics.", "label": "Investment Characteristic Type [Axis]" } } }, "auth_ref": [] }, "ohi_InvestmentCharacteristicTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentCharacteristicTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "Information related to investment characteristics domain.", "label": "Investment Characteristic Type [Domain]" } } }, "auth_ref": [] }, "ohi_InvestmentInJointVenturesAndEntitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentInJointVenturesAndEntitiesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment In Joint Ventures And Entities [Line Items]", "label": "Investment In Joint Ventures And Entities [Line Items]" } } }, "auth_ref": [] }, "ohi_InvestmentInJointVenturesAndEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentInJointVenturesAndEntitiesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment In Joint Ventures And Entities [Table].", "label": "Investment In Joint Ventures And Entities [Table]" } } }, "auth_ref": [] }, "ohi_InvestmentIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentIncomeExpense", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Investment income (expense).", "label": "Investment Income Expense", "terseLabel": "Other (expense) income - net" } } }, "auth_ref": [] }, "ohi_InvestmentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentInterestRateDuringPeriod", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment during the period.", "label": "Investment Interest Rate During the Period", "terseLabel": "Interest rate during the period" } } }, "auth_ref": [] }, "us-gaap_InvestmentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentMaturityDate", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Investment Maturity Date", "terseLabel": "Investment maturity date", "documentation": "Maturity date of investment, in YYYY-MM-DD format." } } }, "auth_ref": [ "r832", "r833", "r835", "r836", "r838", "r839", "r854", "r855", "r1028", "r1199", "r1200" ] }, "ohi_InvestmentMaturityYear": { "xbrltype": "gYearListItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentMaturityYear", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Year in which investment will mature in YYYY format.", "label": "Investment Maturity Year", "terseLabel": "Maturity year" } } }, "auth_ref": [] }, "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Face Amount", "terseLabel": "Financing receivable, face amount", "documentation": "Nominal or face amount on the investment owned." } } }, "auth_ref": [ "r1372" ] }, "ohi_InvestmentTypeCharacteristicNonRealEstateAndRealEstateRelatedLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentTypeCharacteristicNonRealEstateAndRealEstateRelatedLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment Type Characteristic Non Real Estate And Real Estate Related Loans [Member].", "label": "Investment Type Characteristic Non Real Estate And Real Estate Related Loans [Member]" } } }, "auth_ref": [] }, "ohi_InvestmentTypeCharacteristicNonRealEstateRelatedLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentTypeCharacteristicNonRealEstateRelatedLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment Type Characteristic Non Real Estate Related Loans [Member].", "label": "Investment Type Characteristic Non Real Estate Related Loans [Member]" } } }, "auth_ref": [] }, "ohi_InvestmentTypeCharacteristicRealEstateRelatedLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentTypeCharacteristicRealEstateRelatedLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment Type Characteristic Real Estate Related Loans [Member].", "label": "Investment Type Characteristic Real Estate Related Loans [Member]" } } }, "auth_ref": [] }, "ohi_InvestmentWeightedAverageYearsToMaturity": { "xbrltype": "durationItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "InvestmentWeightedAverageYearsToMaturity", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average years to investment maturity.", "label": "Investment Weighted Average Years to Maturity", "terseLabel": "Weighted Average years to Maturity" } } }, "auth_ref": [] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Investments", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Total Investments", "totalLabel": "Total investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r721", "r723", "r1022", "r1023", "r1024", "r1025" ] }, "us-gaap_InvestmentsAndOtherNoncurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentsAndOtherNoncurrentAssetsTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivable" ], "lang": { "en-us": { "role": { "label": "Investments and Other Noncurrent Assets [Text Block]", "terseLabel": "NON-REAL ESTATE LOANS RECEIVABLE", "documentation": "The entire disclosure for investments and other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Labor and Related Expense", "terseLabel": "Compensation", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r708", "r897", "r1165" ] }, "ohi_LakewayRealtyLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "LakewayRealtyLLCMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Lakeway Realty L L C [Member].", "label": "Lakeway Realty LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_Land": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Land", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Land", "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale." } } }, "auth_ref": [ "r1149" ] }, "us-gaap_LeaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseIncome", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Lease Income", "terseLabel": "Rental income", "totalLabel": "Total rental income", "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor." } } }, "auth_ref": [ "r652" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LegalEntityAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "ohi_LessorConstructionAndCapitalCommitmentsUnderLeaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "LessorConstructionAndCapitalCommitmentsUnderLeaseAgreementsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Lessor construction and capital commitments under lease agreements.", "label": "Lessor construction and capital commitments under lease agreements" } } }, "auth_ref": [] }, "ohi_LetterOfCreditUsedAgainstUncollectibleReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "LetterOfCreditUsedAgainstUncollectibleReceivables", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails" ], "lang": { "en-us": { "role": { "documentation": "Letter of credit used against uncollectible receivables.", "label": "Letter of Credit Used Against Uncollectible Receivables", "terseLabel": "Letter of credit used against uncollectible receivables" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Total Liabilities", "negatedTotalLabel": "Total Liabilities", "totalLabel": "Total liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r16", "r53", "r54", "r55", "r58", "r59", "r60", "r61", "r216", "r220", "r221", "r325", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r389", "r390", "r528", "r533", "r534", "r635", "r790", "r903", "r930", "r1039", "r1243", "r1329", "r1330" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Total Liabilities and Stockholders' Equity", "totalLabel": "Total liabilities and equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r69", "r113", "r732", "r1008", "r1022", "r1023", "r1170", "r1174", "r1202", "r1321" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity", "terseLabel": "LIABILITIES AND EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure", "totalLabel": "Total", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r610", "r1304" ] }, "ohi_LibertyJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "LibertyJointVentureMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Liberty Joint Venture [Member].", "label": "Liberty Joint Venture [Member]" } } }, "auth_ref": [] }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Partnership Units Outstanding", "documentation": "The number of limited partner units outstanding." } } }, "auth_ref": [ "r99" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LineOfCredit", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Line of Credit", "verboseLabel": "Revolving credit facility", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r16", "r111", "r1340" ] }, "us-gaap_LinesOfCreditFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LinesOfCreditFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Lines Of Credit, Fair Value Disclosure", "terseLabel": "Revolving line of credit", "documentation": "Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time." } } }, "auth_ref": [ "r1305", "r1313", "r1316", "r1317", "r1318", "r1320" ] }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivables" ], "lang": { "en-us": { "role": { "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS", "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses." } } }, "auth_ref": [ "r646", "r1195" ] }, "ohi_LoansPreviouslyWrittenOffCashRecoveriesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "LoansPreviouslyWrittenOffCashRecoveriesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Loans Previously Written Off Cash Recoveries [Member].", "label": "Loans Previously Written Off Cash Recoveries [Member]" } } }, "auth_ref": [] }, "us-gaap_LoansReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LoansReceivableMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Other Real Estate Loans [Member]", "documentation": "Amount of money and property lent to borrower in exchange for promise to repay amount borrowed plus interest at date certain in future." } } }, "auth_ref": [ "r884", "r1006" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongLivedAssetsHeldForSaleLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongLivedAssetsHeldForSaleLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Assets Held-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r16", "r1233", "r1234", "r1235" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r16", "r36", "r1233", "r1234", "r1235" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r270", "r371", "r372", "r373", "r377", "r495", "r763", "r924", "r1238", "r1239" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r270", "r371", "r372", "r373", "r377", "r495", "r763", "r924", "r1238", "r1239" ] }, "ohi_MaplewoodRealEstateHoldingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MaplewoodRealEstateHoldingsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information regarding maplewood real estate holdings.", "label": "Maplewood Real Estate Holdings" } } }, "auth_ref": [] }, "ohi_MarylandAndWestVirginiaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MarylandAndWestVirginiaMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails" ], "lang": { "en-us": { "role": { "documentation": "Maryland And West Virginia [Member].", "label": "Maryland And West Virginia [Member]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MaximumMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r133", "r135", "r137", "r138", "r140", "r153", "r155", "r156", "r169", "r170", "r270", "r372", "r373", "r374", "r375", "r454", "r484", "r485", "r486", "r495", "r612", "r668", "r755", "r756", "r763", "r782", "r783", "r832", "r835", "r839", "r840", "r854", "r861", "r862", "r864", "r865", "r880", "r881", "r916", "r931", "r936", "r940", "r943", "r944", "r1002", "r1003", "r1004", "r1005", "r1019", "r1247", "r1331", "r1332", "r1333", "r1334", "r1335", "r1336" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r1088" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1088" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MinimumMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r133", "r135", "r137", "r138", "r140", "r153", "r155", "r156", "r169", "r170", "r270", "r372", "r373", "r374", "r375", "r454", "r484", "r485", "r486", "r495", "r612", "r668", "r755", "r756", "r763", "r782", "r783", "r832", "r835", "r839", "r840", "r854", "r861", "r862", "r864", "r865", "r880", "r881", "r916", "r931", "r936", "r940", "r943", "r944", "r1002", "r1003", "r1004", "r1019", "r1247", "r1331", "r1332", "r1333", "r1334", "r1335", "r1336" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r68", "r112", "r216", "r220", "r221", "r325", "r380", "r383", "r384", "r385", "r389", "r390", "r731", "r793", "r1321" ] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Operating Partnership Units Distributions", "negatedLabel": "Omega OP Units distributions", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r98" ] }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestDecreaseFromRedemptions", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityNoncontrollingInterestDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "terseLabel": "Redeemed noncontrolling interest, amount", "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)." } } }, "auth_ref": [ "r41", "r98", "r102" ] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Ownership by noncontrolling interest", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Ownership by parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ohi_MinorityInterestRedeemableShareCountForParentCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MinorityInterestRedeemableShareCountForParentCommonStock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityNoncontrollingInterestDetails" ], "lang": { "en-us": { "role": { "documentation": "Minority interest redeemable share count for parent common stock.", "label": "Minority Interest Redeemable Share Count For Parent Common Stock", "terseLabel": "Number of shares redeemable for Omega common stock" } } }, "auth_ref": [] }, "ohi_MinorityInterestSharesRedeemed": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MinorityInterestSharesRedeemed", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityNoncontrollingInterestDetails" ], "lang": { "en-us": { "role": { "documentation": "Minority interest shares redeemed.", "label": "Minority Interest Shares Redeemed", "terseLabel": "Redeemed noncontrolling interest, shares" } } }, "auth_ref": [] }, "ohi_MinorityInterestStockConversionRatioUponRedemption": { "xbrltype": "pureItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MinorityInterestStockConversionRatioUponRedemption", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityNoncontrollingInterestDetails" ], "lang": { "en-us": { "role": { "documentation": "Minority interest, stock conversion ratio upon redemption.", "label": "Minority Interest, Stock Conversion Ratio Upon Redemption", "terseLabel": "Minority interest, stock conversion ratio upon redemption" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r1107" ] }, "ohi_MonthlyExpectedPaymentAmountToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MonthlyExpectedPaymentAmountToBeReceived", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Monthly expected payment amount to be received.", "label": "Monthly Expected Payment Amount To Be Received", "terseLabel": "Monthly expected payment amount to be received" } } }, "auth_ref": [] }, "ohi_MortgageNoteDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MortgageNoteDue2026Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Mortgage Note Due 2026 [Member].", "label": "Mortgage Note Due 2026 [Member]" } } }, "auth_ref": [] }, "ohi_MortgageReceivablesAndOtherRealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MortgageReceivablesAndOtherRealEstateAbstract", "lang": { "en-us": { "role": { "documentation": "Real estate loans consist of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in the related properties, corporate guarantees and/or personal guarantees", "label": "REAL ESTATE LOANS RECEIVABLE [Abstract]" } } }, "auth_ref": [] }, "ohi_MortgageReceivablesAndOtherRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "MortgageReceivablesAndOtherRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables" ], "lang": { "en-us": { "role": { "documentation": "Mortgage receivables and other real estate loans member.", "label": "Mortgage Receivables and Other Real Estate Loans [Member]" } } }, "auth_ref": [] }, "us-gaap_MortgageReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MortgageReceivablesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Mortgage Receivable [Member]", "documentation": "Amounts due the Company for loans secured by the collateral of specified real estate property and which loan the borrower (debtor) is obligated to repay in accordance with a predetermined set of payments." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r1115" ] }, "stpr_NC": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "NC", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "North Carolina" } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r1089" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations, Total", "totalLabel": "Net cash (used in) provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r211" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total", "totalLabel": "Net cash provided by (used in) investing activities", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r211" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total", "totalLabel": "Net cash provided by operating activities", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r87", "r88", "r89" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common stockholders", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r78", "r89", "r116", "r174", "r178", "r189", "r192", "r196", "r216", "r220", "r221", "r224", "r231", "r235", "r236", "r237", "r238", "r239", "r242", "r243", "r254", "r325", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r389", "r390", "r421", "r424", "r426", "r430", "r492", "r518", "r525", "r608", "r635", "r737", "r810", "r825", "r826", "r895", "r897", "r899", "r1037", "r1243" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net income attributable to noncontrolling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r49", "r103", "r189", "r192", "r239", "r242", "r243", "r736", "r1164" ] }, "ohi_NetIncomeLossAttributableToOpUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NetIncomeLossAttributableToOpUnits", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Net income (loss) attributable to OP Units.", "label": "Net Income Loss Attributable to OP Units", "verboseLabel": "Add: net income attributable to OP Units" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic, Total", "totalLabel": "Net income available to common stockholders - basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r174", "r203", "r235", "r236", "r237", "r238", "r246", "r247", "r255", "r258", "r424", "r426", "r430", "r525" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net income available to common stockholders - diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r203", "r248", "r250", "r251", "r252", "r253", "r255", "r258" ] }, "us-gaap_NetInvestmentHedgeDerivativeLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetInvestmentHedgeDerivativeLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments in Hedges, Net Investment in Foreign Operations, Liabilities, Fair Value", "terseLabel": "Net investment hedges recorded at fair value, liability", "documentation": "Fair value of all derivative liabilities designated as hedges of net investment in foreign operations." } } }, "auth_ref": [ "r1292", "r1293", "r1294", "r1295" ] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [] }, "ohi_NetOperatingIncomeFromUnconsolidatedEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NetOperatingIncomeFromUnconsolidatedEntities", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of net operating income (loss) from unconsolidated entities.", "label": "Net Operating Income From Unconsolidated Entities", "terseLabel": "Net operating income from unconsolidated entities" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicy" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r1088" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r1052", "r1062", "r1072", "r1096", "r1104" ] }, "ohi_NonOperatingNetLossFromUnconsolidatedEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NonOperatingNetLossFromUnconsolidatedEntities", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of non-operating income (loss) from unconsolidated entities.", "label": "Non Operating Net Loss From Unconsolidated Entities", "terseLabel": "Non-operating net loss from unconsolidated entities" } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1079" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1078" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r1096" ] }, "ohi_NonRealEstateLoansReceivable2LoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NonRealEstateLoansReceivable2LoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Non Real Estate Loans Receivable 2 Loans [Member].", "label": "Non Real Estate Loans Receivable 2 Loans [Member]" } } }, "auth_ref": [] }, "ohi_NonRealEstateLoansReceivable3LoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NonRealEstateLoansReceivable3LoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails" ], "lang": { "en-us": { "role": { "documentation": "Non Real Estate Loans Receivable 3 Loans [Member].", "label": "Non Real Estate Loans Receivable 3 Loans [Member]" } } }, "auth_ref": [] }, "ohi_NonRealEstateLoansReceivableOneLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NonRealEstateLoansReceivableOneLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Non Real Estate Loans Receivable One Loan [Member].", "label": "Non Real Estate Loans Receivable One Loan [Member]" } } }, "auth_ref": [] }, "ohi_NonRealEstateRelatedNoteReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NonRealEstateRelatedNoteReceivablesAbstract", "lang": { "en-us": { "role": { "documentation": "Non real estate related note receivables", "label": "NON-REAL ESTATE LOANS RECEIVABLE [Abstract]" } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1115" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1115" ] }, "ohi_NonRule10b51ArrangementModified": { "xbrltype": "booleanItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NonRule10b51ArrangementModified", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Non Rule 10b5-1 Arrangement Modified.", "label": "Non Rule 10b5-1 Arrangement Modified" } } }, "auth_ref": [] }, "ohi_NoncashAcquisitionOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NoncashAcquisitionOfRealEstate", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "documentation": "Value of non-cash acquisition of real estate.", "label": "Noncash Acquisition Of Real Estate", "negatedLabel": "Non-cash acquisition of real estate", "terseLabel": "Non-cash acquisition of real estate" } } }, "auth_ref": [] }, "ohi_NoncashInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NoncashInvestingActivitiesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Noncash Investing Activities [Abstract]", "terseLabel": "Non cash investing activities" } } }, "auth_ref": [] }, "us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncashOrPartNoncashAcquisitionInvestmentsAcquired1", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Acquisition, Investments Acquired", "negatedLabel": "Non-cash investment in real estate loans receivable", "documentation": "The amount of investments that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received", "terseLabel": "Non cash proceeds from sale of real estate investments", "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r39", "r445", "r1177", "r1178", "r1179", "r1180", "r1378" ] }, "ohi_NoncontrollingInterestOperatingPartnershipUnits": { "xbrltype": "sharesItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NoncontrollingInterestOperatingPartnershipUnits", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents noncontrolling interest operating partnership units.", "label": "Noncontrolling Interest Operating Partnership Units", "terseLabel": "Noncontrolling interest - Omega OP Units" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense)", "verboseLabel": "Other income (expense)" } } }, "auth_ref": [] }, "ohi_NorthCarolinaAndVirginiaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NorthCarolinaAndVirginiaMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "documentation": "North Carolina and Virginia [Member].", "label": "North Carolina and Virginia" } } }, "auth_ref": [] }, "us-gaap_NotesPayableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesPayableFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Fair Value Disclosure", "verboseLabel": "Notes Payable", "documentation": "Fair value portion of notes payable." } } }, "auth_ref": [ "r16", "r53", "r54", "r1305", "r1313", "r1316", "r1317", "r1318", "r1320" ] }, "us-gaap_NotesReceivableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesReceivableFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Notes Receivable, Fair Value Disclosure", "terseLabel": "Real estate loans receivable - net", "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date." } } }, "auth_ref": [ "r1316", "r1317", "r1318", "r1320" ] }, "us-gaap_NotesReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesReceivableMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Non Real Estate Loans Receivable [Member]", "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics." } } }, "auth_ref": [] }, "us-gaap_NotesReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesReduction", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Notes Reduction", "terseLabel": "Non-cash collection of real estate loan receivable principal", "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "ohi_NumberOfBorrowers": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfBorrowers", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of borrowers.", "label": "Number of Borrowers" } } }, "auth_ref": [] }, "ohi_NumberOfFixedRateMortgage": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfFixedRateMortgage", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This element represents number of fixed rate mortgages.", "label": "Number Of Fixed Rate Mortgage", "terseLabel": "Number of fixed rate mortgage" } } }, "auth_ref": [] }, "us-gaap_NumberOfForeignCurrencyDerivativesHeld": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfForeignCurrencyDerivativesHeld", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Number of foreign currency derivatives held", "documentation": "Number of foreign currency exchange rate derivatives held by the entity at the reporting date." } } }, "auth_ref": [ "r1290", "r1291" ] }, "ohi_NumberOfForeignCurrencyForwardsEnteredInto": { "xbrltype": "positiveIntegerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfForeignCurrencyForwardsEnteredInto", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of foreign currency forwards entered into.", "label": "Number Of Foreign Currency Forwards Entered Into", "terseLabel": "Number of foreign currency forwards entered into" } } }, "auth_ref": [] }, "ohi_NumberOfIndependentHealthcareOperatingCompaniesOperatingUnderMortgageNotesReceivable": { "xbrltype": "positiveIntegerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfIndependentHealthcareOperatingCompaniesOperatingUnderMortgageNotesReceivable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of independent healthcare operating companies operating under mortgage notes receivable", "label": "Number of independent healthcare operating companies operating under mortgage notes receivable", "terseLabel": "Number of independent healthcare operating companies operating under mortgage notes receivable" } } }, "auth_ref": [] }, "ohi_NumberOfLoansRealEstate": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfLoansRealEstate", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of loans real estate.", "label": "Number of Loans Real Estate", "terseLabel": "Number of loans, real estate" } } }, "auth_ref": [] }, "ohi_NumberOfNonRealEstateLoans": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfNonRealEstateLoans", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of non real estate loans within investment entity with substantial portion of business acquiring and holding investment.", "label": "Number of Non Real Estate Loans", "terseLabel": "Number of non real estate loans receivable" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Number of Operating Segments", "terseLabel": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r911", "r1189" ] }, "ohi_NumberOfOperators": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfOperators", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of third party tenants, mortgages and their affiliates who manage and/or operate the entity's properties.", "label": "Number of operators", "verboseLabel": "Number of operators" } } }, "auth_ref": [] }, "ohi_NumberOfOperatorsPlacedOnCashBasis": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfOperatorsPlacedOnCashBasis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of operators placed on a cash basis.", "label": "Number Of Operators Placed On A Cash Basis" } } }, "auth_ref": [] }, "ohi_NumberOfOperatorsThatMetOrExceededTenPercentOfInvestments": { "xbrltype": "positiveIntegerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfOperatorsThatMetOrExceededTenPercentOfInvestments", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of operators that met or exceeded ten percent of investments.", "label": "Number of Operators That Met or Exceeded Ten Percent Of Investments", "terseLabel": "Number of operators that met or exceeded ten percent of investments" } } }, "auth_ref": [] }, "ohi_NumberOfOperatorsThatMetOrExceededTenPercentThresholdForRevenues": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfOperatorsThatMetOrExceededTenPercentThresholdForRevenues", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of operators that met or exceeded ten percent threshold for revenues.", "label": "Number of Operators That Met or Exceeded Ten Percent Threshold for Revenues", "terseLabel": "Number of operators that met or exceeded ten percent threshold for revenues" } } }, "auth_ref": [] }, "ohi_NumberOfOtherNotesOutstanding": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfOtherNotesOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of other notes outstanding.", "label": "Number of Other Notes Outstanding", "terseLabel": "Number of other notes outstanding" } } }, "auth_ref": [] }, "ohi_NumberOfOtherRealEstateLoans": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfOtherRealEstateLoans", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of other real estate loans within investment in real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "Number of Other Real Estate Loans", "terseLabel": "Number of other real estate loans" } } }, "auth_ref": [] }, "ohi_NumberOfProjects": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfProjects", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of real estate projects in which entity is involved.", "label": "Number of projects" } } }, "auth_ref": [] }, "us-gaap_NumberOfRealEstateProperties": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfRealEstateProperties", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Number of real estate properties", "positiveVerboseLabel": "Number of Facilities", "terseLabel": "Number of real estate properties", "documentation": "The number of real estate properties owned as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments", "verboseLabel": "Number of reportable segment", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r905", "r915", "r1189" ] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Number of States in which Entity Operates", "verboseLabel": "Number of states", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "ohi_NumberOfUnconsolidatedEntities": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfUnconsolidatedEntities", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of unconsolidated entities.", "label": "Number of Unconsolidated Entities", "terseLabel": "Number of unconsolidated entities" } } }, "auth_ref": [] }, "ohi_NumberOfVariableInterestLoans": { "xbrltype": "integerItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "NumberOfVariableInterestLoans", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of variable interest loans.", "label": "Number of Variable Interest Loans", "terseLabel": "Number of variable interest loans" } } }, "auth_ref": [] }, "ohi_O2025Q4DividendsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "O2025Q4DividendsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "documentation": "O 2025 Q4 Dividends [Member].", "label": "O 2025 Q4 Dividends [Member]" } } }, "auth_ref": [] }, "ohi_O2026Q1DividendsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "O2026Q1DividendsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "documentation": "O 2026 Q1 Dividends [Member].", "label": "O 2026 Q1 Dividends [Member]" } } }, "auth_ref": [] }, "ohi_O2026Q2DividendsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "O2026Q2DividendsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfCommonStockDividendsDetails" ], "lang": { "en-us": { "role": { "documentation": "O 2026 Q2 Dividends [Member].", "label": "O 2026 Q2 Dividends [Member]" } } }, "auth_ref": [] }, "stpr_OH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "OH", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Ohio" } } }, "auth_ref": [] }, "ohi_OHIHealthcarePropertiesLimitedPartnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OHIHealthcarePropertiesLimitedPartnershipMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "A general or limited ownership interest in a partnership or unincorporated joint venture.", "label": "Omega OP Units" } } }, "auth_ref": [] }, "us-gaap_OffBalanceSheetCreditLossLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OffBalanceSheetCreditLossLiability", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": "ohi_TotalReceivableAllowanceForCreditLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Off-Balance-Sheet, Credit Loss, Liability", "periodEndLabel": "CECL Ending balance, unfunded loan commitments", "periodStartLabel": "CECL Beginning balance, unfunded loan commitments", "documentation": "Amount of expected credit loss for credit exposure on off-balance-sheet commitment, including but not limited to, loan commitment, standby letter of credit, financial guarantee not accounted for as insurance. Excludes off-balance sheet credit exposure accounted for as insurance and instrument accounted for under derivatives and hedging." } } }, "auth_ref": [ "r329", "r376" ] }, "us-gaap_OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": "ohi_TotalReceivableCreditLossExpenseReversal", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Off-Balance-Sheet, Credit Loss, Liability, Credit Loss Expense (Reversal)", "terseLabel": "Provision (Recovery) for Credit Losses, unfunded loan commitments", "documentation": "Amount of expense (reversal of expense) for expected credit loss for off-balance sheet credit exposure. Excludes off-balance sheet credit exposure accounted for as insurance and instrument accounted for under derivatives and hedging." } } }, "auth_ref": [ "r205", "r330" ] }, "us-gaap_OffBalanceSheetCreditLossLiabilityRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OffBalanceSheetCreditLossLiabilityRollforward", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Unfunded loan commitments, Credit Loss, Liability [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ohi_OmegaCreditAgreement2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OmegaCreditAgreement2025Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "Omega Credit Agreement 2025 [Member].", "label": "Omega Credit Agreement 2025 [Member]", "terseLabel": "2025 Omega Credit Agreement" } } }, "auth_ref": [] }, "ohi_OmegaHealthcareAndOtherDipSponsorLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OmegaHealthcareAndOtherDipSponsorLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Omega Healthcare And Other DIP sponsor loan member.", "label": "Omega Healthcare And Other DIP Sponsor Loan [Member]" } } }, "auth_ref": [] }, "ohi_OmegaHealthcareAndOtherDipSuperPrioritySecuredLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OmegaHealthcareAndOtherDipSuperPrioritySecuredLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Omega Healthcare And Other DIP Super Priority Secured Loan [Member].", "label": "Omega Healthcare And Other DIP Super Priority Secured Loan [Member]" } } }, "auth_ref": [] }, "ohi_OmegaHealthcareDipSponsorLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OmegaHealthcareDipSponsorLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Omega Healthcare DIP sponsor loan member.", "label": "Omega Healthcare DIP Sponsor Loan [Member]" } } }, "auth_ref": [] }, "ohi_OmegaHealthcareDipSuperPrioritySecuredLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OmegaHealthcareDipSuperPrioritySecuredLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails" ], "lang": { "en-us": { "role": { "documentation": "Omega Healthcare DIP Super Priority Secured Loan [Member].", "label": "Omega Healthcare DIP Super Priority Secured Loan [Member]" } } }, "auth_ref": [] }, "ohi_OneNewRealEstateLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OneNewRealEstateLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "One New Real Estate Loan [Member].", "label": "One New Real Estate Loan [Member]" } } }, "auth_ref": [] }, "ohi_OneOfSevenFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OneOfSevenFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "One of Seven Facilities [Member].", "label": "1 of 7 Facilities" } } }, "auth_ref": [] }, "ohi_OperatingAndDirectFinanceLeaseLeaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OperatingAndDirectFinanceLeaseLeaseIncomeTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from operating and direct finance leases.", "label": "Operating And Direct Finance Lease Lease Income [Table Text Block]", "terseLabel": "Schedule of operating and direct financing lease income" } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Costs and Expenses", "negatedLabel": "Property-level expenses", "terseLabel": "Property-level expenses", "totalLabel": "Total property level expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Total Operating Expenses", "totalLabel": "Total expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [ "r899" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Expenses", "verboseLabel": "Expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Income Before Other Income and Expense", "totalLabel": "Net operating income", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r124", "r895", "r899", "r904", "r1182", "r1190", "r1192", "r1193", "r1194" ] }, "us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseIncomeComprehensiveIncomeExtensibleList", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Rental income, Statement of Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes operating lease income." } } }, "auth_ref": [ "r651" ] }, "us-gaap_OperatingLeaseLeaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLeaseIncome", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Lease Income", "verboseLabel": "Rental income", "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable." } } }, "auth_ref": [ "r264", "r651", "r652" ] }, "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLeaseIncomeLeasePayments", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails": { "parentTag": "us-gaap_LeaseIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Lease Income, Lease Payments", "terseLabel": "Fixed income from operating leases", "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable." } } }, "auth_ref": [ "r264", "r654" ] }, "us-gaap_OperatingLeaseVariableLeaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseVariableLeaseIncome", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails": { "parentTag": "us-gaap_LeaseIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfOperatingAndDirectFinancingLeaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Variable Lease Income", "terseLabel": "Variable income from operating leases", "documentation": "Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable." } } }, "auth_ref": [ "r264", "r655" ] }, "ohi_OperatingPortfolioSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OperatingPortfolioSegmentMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Operating Portfolio Segment [Member].", "label": "Operating Portfolio Segment [Member]", "terseLabel": "Operating segment" } } }, "auth_ref": [] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "terseLabel": "Operating segment", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r302", "r305", "r910", "r911" ] }, "ohi_OperatorOfFourCareHomesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OperatorOfFourCareHomesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Operator Of Four Care Homes [Member].", "label": "Operator Of Four Care Homes [Member]" } } }, "auth_ref": [] }, "ohi_OperatorPlacedOnCashBasisMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OperatorPlacedOnCashBasisMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Operator Placed On Cash Basis [Member].", "label": "Operator Placed On Cash Basis [Member]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicy" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r90", "r100", "r1169" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets", "verboseLabel": "Other assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r106", "r182", "r724", "r911", "r1022", "r1023", "r1039" ] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingLocationAndFairValueOfDerivativeInstrumentsDesignatedAsHedgesDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r996" ] }, "ohi_OtherCollateralMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherCollateralMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Collateral [Member]", "label": "Other Collateral [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCommitment", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Commitment To Fund Construction Of New Leased And Mortgaged Facilities", "terseLabel": "Total commitments", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [ "r1171", "r1176", "r1337" ] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCommitmentsAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCommitmentsDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherCommitmentsTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Table Text Block]", "verboseLabel": "Schedule of remaining commitments", "documentation": "Tabular disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "positiveLabel": "Unrealized gain (loss)", "terseLabel": "Cash flow hedges", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r185", "r186", "r738" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax", "terseLabel": "Realized gain", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r186", "r188" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r738" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive (loss) income", "totalLabel": "Total other comprehensive income (loss)", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r12", "r15", "r190", "r193", "r198", "r239", "r638", "r639", "r644", "r709", "r738", "r1162", "r1163" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive income attributable to noncontrolling interest", "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests." } } }, "auth_ref": [ "r5", "r11", "r101", "r190", "r193", "r239" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss)" } } }, "auth_ref": [] }, "ohi_OtherHealthcareJointVentureInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherHealthcareJointVentureInvestmentsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Healthcare Joint Venture Investments [Member].", "label": "Other Healthcare Joint Venture Investments [Member]" } } }, "auth_ref": [] }, "ohi_OtherLoansReceivableMaturingIn2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherLoansReceivableMaturingIn2026Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Loans Receivable Maturing in 2026 [Member].", "label": "Other Loans Receivable Maturing in 2026 [Member]" } } }, "auth_ref": [] }, "ohi_OtherLoansReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherLoansReceivableMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Loans Receivable [Member].", "label": "Other Loans Receivable [Member]" } } }, "auth_ref": [] }, "ohi_OtherLoansReceivableOneLoanPastDuePrincipalOf6.4MillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherLoansReceivableOneLoanPastDuePrincipalOf6.4MillionMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Loans Receivable One Loan Past Due Principal of 6.4Million [Member].", "label": "Other Loans Receivable One Loan Past Due Principal of 6.4 Million [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other Noncash Income (Expense)", "negatedLabel": "Other non-cash items", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r89" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest and Other Income", "totalLabel": "Total other income", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r81", "r979" ] }, "us-gaap_OtherOperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherOperatingIncome", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Operating Income", "terseLabel": "Miscellaneous income", "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r74" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1088" ] }, "ohi_OtherRealEstateJointVentureInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherRealEstateJointVentureInvestmentsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Real Estate Joint Venture Investments [Member].", "label": "Other Real Estate Joint Venture Investments [Member]" } } }, "auth_ref": [] }, "ohi_OtherRealEstateJointVenturesAndOtherHealthcareJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherRealEstateJointVenturesAndOtherHealthcareJointVenturesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Real Estate Joint Ventures And Other Healthcare Joint Ventures [Member].", "label": "Other Real Estate Joint Ventures And Other Healthcare Joint Ventures [Member]" } } }, "auth_ref": [] }, "ohi_OtherRealEstateLoansDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "OtherRealEstateLoansDue2026Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Other real estate loans due 2026 [Member].", "label": "Other Real Estate Loans Due 2026 [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1050", "r1060", "r1070", "r1102" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r1053", "r1063", "r1073", "r1105" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1053", "r1063", "r1073", "r1105" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "OwnershipAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "OwnershipDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ParentMember", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Total Stockholders' Equity [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1077" ] }, "us-gaap_PaymentsForCapitalImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForCapitalImprovements", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments For Capital Improvements", "negatedLabel": "Capital improvements to real estate investments", "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use." } } }, "auth_ref": [ "r84" ] }, "ohi_PaymentsForCapitalImprovementsAndConstructionInProgess": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PaymentsForCapitalImprovementsAndConstructionInProgess", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use and construction in progess items.", "label": "Payments For Capital Improvements And Construction In Progess", "terseLabel": "Payments for construction in progress and capital improvement programs" } } }, "auth_ref": [] }, "us-gaap_PaymentsForConstructionInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForConstructionInProcess", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for Construction in Process", "negatedLabel": "Investments in construction in progress", "documentation": "The cash outflow from construction costs to date on capital projects that have not been completed and assets being constructed that are not ready to be placed into service." } } }, "auth_ref": [ "r84" ] }, "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForProceedsFromHedgeInvestingActivities", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for (Proceeds from) Hedge, Investing Activities", "negatedLabel": "Proceeds from foreign currency forward contracts", "terseLabel": "Payments for (proceeds from) derivative instruments", "documentation": "The cash outflow or inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments Of Debt Issuance Costs", "negatedLabel": "Payments of financing related costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r26" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments Of Dividends", "negatedLabel": "Dividends paid", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r85" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Payments to acquire businesses, gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r24", "r520", "r940", "r942", "r972" ] }, "us-gaap_PaymentsToAcquireCommercialRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireCommercialRealEstate", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments To Acquire Commercial Real Estate", "negatedLabel": "Acquisition of real estate", "terseLabel": "Payment for real estate acquisition", "documentation": "The cash outflow from the acquisition of property as primarily intended to generate income for its owner." } } }, "auth_ref": [ "r84" ] }, "us-gaap_PaymentsToAcquireInterestInJointVenture": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireInterestInJointVenture", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Interest in Joint Venture", "negatedLabel": "Investments in unconsolidated entities", "verboseLabel": "Investments in joint venture", "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group." } } }, "auth_ref": [ "r24" ] }, "ohi_PaymentsToAcquireLoanReceivableCollectionOfLoanPrincipalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PaymentsToAcquireLoanReceivableCollectionOfLoanPrincipalNet", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow (inflow) associated with the payments (collection) regarding loans related to real estate.", "label": "Payments To Acquire Loan Receivable Collection of Loan Principal Net", "terseLabel": "Net cash advances (repayments) on loans receivable" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireLoansReceivable", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Loans Receivable", "negatedLabel": "Investment in loan receivables and other", "terseLabel": "Payments to acquire loans receivable", "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services." } } }, "auth_ref": [ "r23" ] }, "us-gaap_PaymentsToAcquireRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireRealEstate", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Real Estate", "terseLabel": "Real Estate Assets Acquired", "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner." } } }, "auth_ref": [ "r84" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r1087" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1087" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1079" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r1096" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r1089" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1078" ] }, "ohi_PercentageOfInitialAnnualCashYield": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PercentageOfInitialAnnualCashYield", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents percentage of initial annual cash yield.", "label": "Percentage of initial annual cash yield" } } }, "auth_ref": [] }, "ohi_PerformanceBasedAwardsPerformancePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PerformanceBasedAwardsPerformancePeriod", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The performance period used for performance based awards.", "label": "Performance Based Awards Performance Period", "terseLabel": "Performance period used for performance based awards" } } }, "auth_ref": [] }, "ohi_PerformanceBasedProfitInterestUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PerformanceBasedProfitInterestUnitsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Performance Based Profit Interest Units [Member].", "label": "Performance Based Profit Interest Units [Member]" } } }, "auth_ref": [] }, "ohi_PerformanceBasedRestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PerformanceBasedRestrictedStockMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock [Member].", "label": "Performance Based Restricted Stock [Member]" } } }, "auth_ref": [] }, "ohi_PerformanceBasedRestrictedStockUnitsAndProfitInterestUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PerformanceBasedRestrictedStockUnitsAndProfitInterestUnitsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Units And Profit Interest Units [Member].", "label": "Performance Based Restricted Stock Units and Profit Interest Units [Member]" } } }, "auth_ref": [] }, "ohi_PerformanceBasedRestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PerformanceBasedRestrictedStockUnitsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Units [Member].", "label": "Performance Based Restricted Stock Units [Member]" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PerformanceSharesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [ "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277" ] }, "ohi_PersonalGuaranteeCollateralMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PersonalGuaranteeCollateralMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Personal Guarantee Collateral [Member]", "label": "Personal Guarantee Collateral [Member]" } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r1080" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r1124" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r1079" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Portion at Fair Value Measurement [Member] [Default]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r622", "r623", "r625", "r626", "r633", "r635", "r636", "r884", "r1319" ] }, "ohi_PotentialEquityInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PotentialEquityInvestmentOwnershipPercentage", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails" ], "lang": { "en-us": { "role": { "documentation": "Potential equity investment percentage.", "label": "Potential Equity Investment, Ownership Percentage", "terseLabel": "Potential equity investment percentage" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r62", "r432" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r62", "r791" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r62", "r432" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r62", "r791", "r809", "r1378", "r1379" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock $1.00 par value authorized - 20,000 shares, issued and outstanding - none", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r62", "r423", "r428", "r727", "r1008" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicy" ], "lang": { "en-us": { "role": { "label": "Reclassification, Policy [Policy Text Block]", "verboseLabel": "Reclassifications", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r1147" ] }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromCollectionOfLoansReceivable", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale and Collection of Mortgage Notes Receivable", "negatedLabel": "Principal repayments received", "verboseLabel": "Collection of loan principal", "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromDivestitureOfInterestInJointVenture", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Divestiture of Interest in Joint Venture", "terseLabel": "Distributions from unconsolidated entities in excess of earnings", "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Equity method investment, proceeds from distribution", "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities." } } }, "auth_ref": [ "r210", "r1166" ] }, "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromInsuranceSettlementInvestingActivities", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Insurance Premiums Collected", "verboseLabel": "Receipts from insurance proceeds", "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities." } } }, "auth_ref": [ "r6", "r20" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common stock", "verboseLabel": "Gross proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds From Issuance Of Other Long Term Debt", "terseLabel": "Proceeds from borrowings", "documentation": "Amount of cash inflow from issuance of long-term debt classified as other." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Net proceeds from issuance of common stock", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r3", "r769" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Total proceeds", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r83" ] }, "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Real Estate Held-for-investment", "verboseLabel": "Net proceeds from sale of real estate investments", "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period." } } }, "auth_ref": [ "r83" ] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r1186" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfComprehensiveIncome", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Profit (Loss) from Real Estate Operations", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r174", "r178", "r189", "r192", "r209", "r216", "r220", "r221", "r224", "r231", "r239", "r242", "r243", "r325", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r389", "r390", "r421", "r492", "r518", "r525", "r526", "r529", "r530", "r608", "r635", "r713", "r715", "r735", "r774", "r810", "r825", "r826", "r974", "r975", "r1038", "r1164", "r1243" ] }, "ohi_PropertyCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PropertyCategoryAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Property Category [Axis].", "label": "Property Category [Axis]" } } }, "auth_ref": [] }, "ohi_PropertyCategoryDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "PropertyCategoryDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Property Category [Domain].", "label": "Property Category [Domain]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAssetsHeldForSaleDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentAssetsHeldForSaleDisclosureAbstract", "lang": { "en-us": { "role": { "label": "ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Type [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r9", "r650" ] }, "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentOtherTypesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Other Types [Member]", "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Type [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r92", "r650" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "negatedLabel": "Recovery (provision) for credit losses", "terseLabel": "(Recovery) provision for credit losses", "verboseLabel": "(Recovery) provision for credit losses", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r202", "r205", "r330" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1077" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r1077" ] }, "stpr_RI": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "RI", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Rhode Island" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r133", "r135", "r137", "r138", "r140", "r153", "r155", "r156", "r169", "r170", "r270", "r372", "r373", "r374", "r375", "r453", "r454", "r484", "r485", "r486", "r491", "r495", "r612", "r662", "r666", "r668", "r755", "r756", "r763", "r782", "r783", "r832", "r835", "r839", "r840", "r854", "r861", "r862", "r864", "r865", "r880", "r881", "r916", "r931", "r936", "r940", "r943", "r944", "r1002", "r1003", "r1004", "r1005", "r1019", "r1028", "r1236", "r1247", "r1306", "r1332", "r1333", "r1334", "r1335", "r1336" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Range [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r133", "r135", "r137", "r138", "r140", "r153", "r155", "r156", "r169", "r170", "r270", "r372", "r373", "r374", "r375", "r453", "r454", "r484", "r485", "r486", "r491", "r495", "r612", "r662", "r666", "r668", "r755", "r756", "r763", "r782", "r783", "r832", "r835", "r839", "r840", "r854", "r861", "r862", "r864", "r865", "r880", "r881", "r916", "r931", "r936", "r940", "r943", "r944", "r1002", "r1003", "r1004", "r1005", "r1019", "r1028", "r1236", "r1247", "r1306", "r1332", "r1333", "r1334", "r1335", "r1336" ] }, "us-gaap_RealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateAbstract", "lang": { "en-us": { "role": { "label": "REAL ESTATE ASSETS [Abstract]" } } }, "auth_ref": [] }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Name of Property [Axis]", "documentation": "Information by name of property." } } }, "auth_ref": [ "r142", "r147", "r868", "r873", "r1133", "r1134", "r1135", "r1136", "r1137", "r1138", "r1139", "r1140", "r1380", "r1381", "r1382", "r1383", "r1384", "r1385", "r1386", "r1387" ] }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Name of Property [Domain]", "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center." } } }, "auth_ref": [ "r142", "r147", "r868", "r873", "r1133", "r1134", "r1135", "r1136", "r1137", "r1138", "r1139", "r1140", "r1380", "r1381", "r1382", "r1383", "r1384", "r1385", "r1386", "r1387" ] }, "us-gaap_RealEstateDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssets" ], "lang": { "en-us": { "role": { "label": "Real Estate Disclosure [Text Block]", "verboseLabel": "REAL ESTATE ASSETS", "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures." } } }, "auth_ref": [ "r117", "r118", "r119", "r120", "r121", "r879" ] }, "us-gaap_RealEstateHeldforsale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateHeldforsale", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "ohi_TotalRealEstateInvestments", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real estate held-for-sale", "terseLabel": "Amount of Assets Held for Sale", "verboseLabel": "Assets held for sale", "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory." } } }, "auth_ref": [ "r1338", "r1339" ] }, "ohi_RealEstateImpairmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RealEstateImpairmentLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Impairment [Line Items].", "label": "Real Estate Impairment [Line Items]" } } }, "auth_ref": [] }, "ohi_RealEstateImpairmentTable": { "xbrltype": "stringItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RealEstateImpairmentTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Impairment [Table]", "label": "Real Estate Impairment [Table]" } } }, "auth_ref": [] }, "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate Investment Property, Accumulated Depreciation", "negatedLabel": "Less accumulated depreciation", "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes." } } }, "auth_ref": [ "r720" ] }, "us-gaap_RealEstateInvestmentPropertyAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateInvestmentPropertyAtCost", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate Investment Property, at Cost", "terseLabel": "Real estate investments", "totalLabel": "Total real estate assets", "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments." } } }, "auth_ref": [ "r721", "r722" ] }, "us-gaap_RealEstateInvestmentPropertyNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateInvestmentPropertyNet", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "ohi_TotalRealEstateInvestments", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate Investment Property, Net", "positiveLabel": "Real estate investments - net", "totalLabel": "Real estate assets - net", "verboseLabel": "Real estate assets - net", "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments." } } }, "auth_ref": [ "r1338", "r1339" ] }, "ohi_RealEstateInvestmentRelatedToLongTermHealthcareFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RealEstateInvestmentRelatedToLongTermHealthcareFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Investment Related to Long Term Healthcare Facilities [Member].", "label": "Real Estate Investment Related to Long Term Healthcare Facilities [Member]" } } }, "auth_ref": [] }, "us-gaap_RealEstateInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateInvestmentsAbstract", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate Investment [Abstract]", "verboseLabel": "Real estate assets" } } }, "auth_ref": [] }, "ohi_RealEstateLoansReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RealEstateLoansReceivableMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Loans Receivable [Member].", "label": "Real Estate Loans Receivable [Member]" } } }, "auth_ref": [] }, "us-gaap_RealEstatePropertiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstatePropertiesAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Real Estate Property Ownership [Axis]", "documentation": "Information by ownership of the property." } } }, "auth_ref": [] }, "us-gaap_RealEstatePropertiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstatePropertiesDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Real Estate Properties [Domain]", "documentation": "Represents categories of ownership of real estate properties." } } }, "auth_ref": [] }, "us-gaap_RealEstatePropertiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstatePropertiesLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Real Estate Properties [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RealEstateTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RealEstateTaxExpense", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Real estate tax expense", "verboseLabel": "Property taxes", "documentation": "A tax based on the assessed value of real estate by the local government. The tax is usually based on the value of property (including the land)." } } }, "auth_ref": [ "r938" ] }, "ohi_RealEstateTaxesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RealEstateTaxesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Taxes [Member].", "label": "Real Estate Taxes [Member]" } } }, "auth_ref": [] }, "us-gaap_ReceivableTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReceivableTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails", "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesScheduleOfRemainingCommitmentsDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Receivable [Domain]", "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates." } } }, "auth_ref": [ "r64", "r70" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r1045", "r1055", "r1065", "r1097" ] }, "ohi_RedemptionOfOpUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RedemptionOfOpUnits", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents Redemption of OP Units.", "label": "Redemption Of Op Units", "negatedLabel": "Redemption of Omega OP Units" } } }, "auth_ref": [] }, "ohi_RelatedToFiveDerivativeInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RelatedToFiveDerivativeInstrumentsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Related To Five Derivative Instruments [Member].", "label": "Related To Five Derivative Instruments [Member]" } } }, "auth_ref": [] }, "ohi_RelatedToTwoDerivativeInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RelatedToTwoDerivativeInstrumentsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Related To Two Derivative Instruments [Member].", "label": "Related To Two Derivative Instruments [Member]" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-term Debt", "negatedLabel": "Payments of borrowings", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r86", "r770" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r166", "r167", "r216", "r225", "r226", "r395", "r434", "r657", "r667", "r721", "r889", "r890", "r891", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1298", "r1299", "r1300", "r1301" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r1046", "r1056", "r1066", "r1098" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r1047", "r1057", "r1067", "r1099" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r1054", "r1064", "r1074", "r1106" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash", "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r27", "r105", "r179", "r215", "r726" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalentsAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents [Abstract]", "verboseLabel": "Reconciliation of cash and cash equivalents and restricted cash:" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained earnings (accumulated deficit)", "terseLabel": "Cumulative net earnings", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r66", "r98", "r730", "r760", "r762", "r771", "r792", "r1008" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsMember", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Cumulative Net Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r171", "r173", "r174", "r228", "r229", "r230", "r232", "r239", "r241", "r243", "r327", "r328", "r359", "r420", "r492", "r507", "r508", "r515", "r516", "r517", "r519", "r524", "r525", "r594", "r596", "r597", "r599", "r606", "r647", "r649", "r757", "r759", "r775", "r1378" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Resident fees and services", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r122", "r123", "r263", "r276", "r277", "r298", "r304", "r308", "r310", "r312", "r449", "r450", "r451", "r669", "r895", "r899" ] }, "ohi_RevenueFromLeasesAndLoanAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RevenueFromLeasesAndLoanAgreements", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Revenue from leases and loan agreements.", "label": "Revenue from Leases and Loan Agreements", "terseLabel": "Revenue from leases and loan agreements" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 }, "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Real Estate Revenue Net", "totalLabel": "Total revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r122", "r123", "r197", "r216", "r220", "r221", "r263", "r276", "r277", "r298", "r304", "r308", "r310", "r312", "r325", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r389", "r390", "r635", "r713", "r715", "r910", "r979", "r1022", "r1023", "r1243" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenuesAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue", "terseLabel": "Revenue", "verboseLabel": "Revenues" } } }, "auth_ref": [] }, "ohi_RevolvingCreditFacilityDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RevolvingCreditFacilityDue2029Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facility Due 2029 [Member].", "label": "Revolving Credit Facility Due 2029 [Member]", "terseLabel": "Revolving Credit Facility 2029" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ohi_RevolvingCreditFacilityReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RevolvingCreditFacilityReceivableMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facility Receivable [Member]", "label": "Revolving Credit Facility Receivable [Member]" } } }, "auth_ref": [] }, "ohi_RevolvingWorkingCapitalLoansReceivableMaturing2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RevolvingWorkingCapitalLoansReceivableMaturing2026Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Revolving Working Capital Loans Receivable Maturing 2026 [Member].", "label": "Revolving Working Capital Loans Receivable Maturing 2026 [Member]" } } }, "auth_ref": [] }, "ohi_RevolvingWorkingCapitalLoansReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RevolvingWorkingCapitalLoansReceivableMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Revolving Working Capital Loans Receivable [Member].", "label": "Revolving Working Capital Loans Receivable [Member]" } } }, "auth_ref": [] }, "ohi_RevolvingWorkingCapitalLoansReceivableOneLoadPastDuePrincipalOf5.9MillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "RevolvingWorkingCapitalLoansReceivableOneLoadPastDuePrincipalOf5.9MillionMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Revolving Working Capital Loans Receivable One Load Past Due Principal of 5.9 Million [Member].", "label": "Revolving Working Capital Loans Receivable One Load Past Due Principal of 5.9 Million [Member]" } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Concentration of Risk [Abstract]" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1115" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1115" ] }, "ohi_Rule10b51ArrangementModified": { "xbrltype": "booleanItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "Rule10b51ArrangementModified", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Rule 10b5-1 Arrangement Modified.", "label": "Rule 10b5-1 Arrangement Modified" } } }, "auth_ref": [] }, "ohi_SHHHoldingsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SHHHoldingsLLCMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "documentation": "S H H Holdings L L C [Member].", "label": "S H H Holdings L L C [Member]", "terseLabel": "Saber PropCo" } } }, "auth_ref": [] }, "ohi_SaberHealthcareHoldingsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SaberHealthcareHoldingsLLCMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Saber Healthcare Holdings L L C [Member].", "label": "Saber Healthcare Holdings L L C [Member]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r312", "r1185", "r1186" ] }, "us-gaap_SalesRevenueProductLineMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SalesRevenueProductLineMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, Product and Service Benchmark [Member]", "documentation": "Revenue from specified product or service, when it serves as benchmark in concentration of risk calculation. Includes, but is not limited to, revenue from contract with customer and other sources." } } }, "auth_ref": [ "r1185", "r1186" ] }, "us-gaap_ScenarioPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScenarioPlanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Scenario, Plan [Member]", "documentation": "The scenario under which facts represent plans as distinct from actual." } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Scenario, Unspecified [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r168", "r175", "r176", "r244", "r455", "r1126" ] }, "ohi_ScheduleOfAccountsNotesLoansAndFinancingReceivableActivityDuringPeriodTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableActivityDuringPeriodTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the activity during the period in accounts, notes, loans and financing receivables, including advances, repayments, etc. during the period.", "label": "Schedule of Accounts, Notes, Loans And Financing Receivable Activity During The Period [Table Text Block]", "terseLabel": "Summary of real estate loan activity", "verboseLabel": "Summary of non-real estate loan activity" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableMaplewoodRevolvingCreditFacilityNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss." } } }, "auth_ref": [ "r64", "r70", "r315", "r1198" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableTables", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Investments", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r64", "r70" ] }, "ohi_ScheduleOfAccountsReceivableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ScheduleOfAccountsReceivableTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the summary of net receivables.", "label": "Schedule Of Accounts Receivable [Table Text Block]", "verboseLabel": "Schedule of Net Accounts Receivable" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of accumulated other comprehensive income (loss)", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r18", "r1322", "r1323" ] }, "ohi_ScheduleOfAtmIssuances": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ScheduleOfAtmIssuances", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure providing shares issued under ATM programs.", "label": "Schedule of ATM Issuances" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Cash Flow Supplemental Disclosures", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of components of income tax expense", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r1280" ] }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesTables" ], "lang": { "en-us": { "role": { "label": "Condensed Income Statement [Table Text Block]", "terseLabel": "Schedule of Variable Interest Entities revenue", "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r1132", "r1171", "r1176", "r1337" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Debt [Table Text Block]", "verboseLabel": "Schedule of Borrowings", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "verboseLabel": "Location and the fair value of derivative instruments designated as hedges", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r546", "r549", "r571", "r996" ] }, "ohi_ScheduleOfDividendReinvestmentAndCommonStockPurchasePlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ScheduleOfDividendReinvestmentAndCommonStockPurchasePlanTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure related to dividend reinvestment and common stock purchase plan.", "label": "Schedule Of Dividend Reinvestment And Common Stock Purchase Plan [Table Text Block]", "terseLabel": "Schedule of dividend reinvestment and common stock purchase plan" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Earnings Per Share, Basic and Diluted [Table Text Block]", "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1181" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r321", "r322", "r324", "r514", "r635", "r1127", "r1128", "r1129", "r1282", "r1283", "r1284", "r1285" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangibles", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r886", "r1225" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Goodwill [Table Text Block]", "verboseLabel": "Schedule of Reconciliation of Goodwill", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r923", "r1208", "r1209", "r1210", "r1211", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218" ] }, "us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfLongLivedAssetsHeldForSaleTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Asset, Held-for-Sale [Table]", "documentation": "Disclosure of information about long-lived asset held for sale. Includes, but is not limited to, description of fact and circumstance leading to expected disposal, manner and timing of disposal, amount of asset held for sale, gain (loss) recognized in statement of income, and statement of income caption that includes gain (loss)." } } }, "auth_ref": [ "r10", "r13" ] }, "us-gaap_ScheduleOfRealEstatePropertiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRealEstatePropertiesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Real Estate Properties [Table]", "documentation": "Disclosure of information about real estate property by ownership of property." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r32", "r33", "r34" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "verboseLabel": "Schedule of reportable segments and significant expense categories by segment", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r32", "r33", "r34" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Schedule Of Share-Based Compensation Arrangements By Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r457", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r491" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table]", "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements." } } }, "auth_ref": [ "r42", "r43", "r44", "r45", "r47", "r527", "r528", "r533", "r534", "r663", "r664", "r665" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table Text Block]", "terseLabel": "Schedule of Variable Interest Entities", "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r42", "r43", "r44", "r45", "r47" ] }, "us-gaap_SecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SecuredDebt", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Secured Debt", "positiveLabel": "Secured borrowings", "terseLabel": "Total secured borrowings", "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower." } } }, "auth_ref": [ "r16", "r111", "r1340" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1040" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1042" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r122", "r123", "r124", "r125", "r263", "r272", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r288", "r289", "r290", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r312", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r358", "r367", "r368", "r521", "r522", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r907", "r910", "r911", "r923", "r1021", "r1342", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370", "r1371" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r134", "r136", "r139", "r141", "r142", "r143", "r144", "r145", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r156", "r268", "r310", "r311", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r713", "r714", "r715", "r716", "r778", "r779", "r780", "r834", "r837", "r841", "r856", "r861", "r863", "r864", "r865", "r868", "r869", "r870", "r871", "r874", "r875", "r876", "r877", "r878", "r885", "r901", "r932", "r933", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1020", "r1028", "r1342", "r1344", "r1345", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370", "r1371" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "SEGMENTS [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegments" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENTS", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r125", "r263", "r271", "r272", "r273", "r274", "r275", "r287", "r289", "r290", "r302", "r303", "r304", "r305", "r306", "r308", "r309", "r312", "r905", "r908", "r909", "r910", "r912", "r914", "r915" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "terseLabel": "SEGMENTS", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingOtherItemAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingOtherItemAmount", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Other Segment Item, Amount", "terseLabel": "Other segment expenses", "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)." } } }, "auth_ref": [ "r263", "r289", "r290", "r304", "r910" ] }, "us-gaap_SegmentReportingOtherItemCompositionDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingOtherItemCompositionDescription", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Other Segment Item, Composition, Description", "terseLabel": "Other segment expenses description", "documentation": "Description of composition of other segment item not separately disclosed." } } }, "auth_ref": [ "r263", "r289", "r290", "r304", "r910" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicy" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segments", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r307", "r310", "r906", "r907", "r913" ] }, "ohi_SeniorHousingExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorHousingExpensesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Senior Housing Expenses [Member].", "label": "Senior Housing Expenses [Member]" } } }, "auth_ref": [] }, "ohi_SeniorNotesAndOtherUnsecuredBorrowingsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesAndOtherUnsecuredBorrowingsNet", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Represents the carrying value of senior notes and other unsecured borrowings net.", "label": "Senior notes and other unsecured borrowings, net", "terseLabel": "Senior notes and other unsecured borrowings - net", "verboseLabel": "Total senior notes and other unsecured borrowings - net" } } }, "auth_ref": [] }, "ohi_SeniorNotesAndOtherUnsecuredBorrowingsNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesAndOtherUnsecuredBorrowingsNetMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Senior notes and other unsecured borrowings - net", "label": "Senior Notes And Other Unsecured Borrowings Net [Member]" } } }, "auth_ref": [] }, "ohi_SeniorNotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesDue2027Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information about Senior Notes Due 2027.", "label": "4.50% notes due 2027" } } }, "auth_ref": [] }, "ohi_SeniorNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesDue2028Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information about Senior Notes Due 2028.", "label": "4.75% notes due 2028" } } }, "auth_ref": [] }, "ohi_SeniorNotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesDue2029Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2029 [Member].", "label": "3.63% notes due 2029" } } }, "auth_ref": [] }, "ohi_SeniorNotesDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesDue2030Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents senior notes due on 2030.", "label": "Senior Notes Due 2030 [Member]", "terseLabel": "5.20% notes due 2030" } } }, "auth_ref": [] }, "ohi_SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesDue2031Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2031 [Member].", "label": "3.38% notes due 2031" } } }, "auth_ref": [] }, "ohi_SeniorNotesDue2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SeniorNotesDue2033Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2033 [Member].", "label": "3.25% notes due 2033" } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SeniorNotesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "ohi_SevenFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SevenFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Seven Facilities [Member].", "label": "7 Facilities" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share Based Compensation", "terseLabel": "Stock-based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period", "verboseLabel": "Vesting period, years", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r937" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Number of restricted stock issued", "terseLabel": "Granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r475" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "PRSUs Granted", "terseLabel": "Shares awarded, other than options", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r472", "r473" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r457", "r459", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r491" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r487" ] }, "ohi_SharesIssuedAveragePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SharesIssuedAveragePricePerShare", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "documentation": "Average per share amount of equity securities issued.", "label": "Shares Issued, Average Price Per Share", "terseLabel": "Average issue price per share" } } }, "auth_ref": [] }, "ohi_SixNewNonRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SixNewNonRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Six New Non Real Estate Loans [Member].", "label": "Six New Non Real Estate Loans [Member]" } } }, "auth_ref": [] }, "ohi_SixOfSevenFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SixOfSevenFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Six of Seven Facilities [Member].", "label": "Six of Seven Facilities [Member]", "terseLabel": "6 of 7 Facilities" } } }, "auth_ref": [] }, "ohi_SkilledNursingFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SkilledNursingFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents skilled nursing facilities.", "label": "Skilled Nursing Facilities [Member]" } } }, "auth_ref": [] }, "ohi_SpecialtyFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "SpecialtyFacilityMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Specialty Facility [Member].", "label": "Specialty Facility" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureTaxesScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "State and Local Income Tax Expense (Benefit), Continuing Operations", "terseLabel": "State and local income tax expense", "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r498", "r1170", "r1175", "r1278", "r1281" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r122", "r123", "r124", "r125", "r177", "r263", "r272", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r288", "r289", "r290", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r312", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r358", "r360", "r367", "r368", "r521", "r522", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r907", "r910", "r911", "r923", "r1021", "r1342", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370", "r1371" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r63", "r67", "r68", "r171", "r173", "r174", "r194", "r195", "r196", "r228", "r229", "r230", "r232", "r239", "r241", "r243", "r265", "r327", "r328", "r359", "r420", "r445", "r492", "r507", "r508", "r515", "r516", "r517", "r519", "r524", "r525", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r606", "r638", "r640", "r641", "r642", "r643", "r644", "r647", "r649", "r656", "r738", "r757", "r758", "r759", "r775", "r827" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableCanadianDevelopmentLoanDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r134", "r136", "r139", "r141", "r142", "r143", "r144", "r145", "r148", "r149", "r150", "r151", "r152", "r154", "r155", "r156", "r268", "r310", "r311", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r713", "r714", "r715", "r716", "r778", "r779", "r780", "r834", "r837", "r841", "r856", "r861", "r863", "r864", "r865", "r868", "r869", "r870", "r871", "r874", "r875", "r876", "r877", "r878", "r885", "r901", "r932", "r933", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1020", "r1028", "r1342", "r1344", "r1345", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370", "r1371" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementLineItems", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r228", "r229", "r230", "r265", "r422", "r423", "r425", "r427", "r649", "r669", "r768", "r776", "r777", "r784", "r785", "r786", "r787", "r788", "r789", "r791", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r808", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r827", "r897", "r899", "r1030", "r1376" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementScenarioAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r168", "r175", "r176", "r244", "r455", "r1126", "r1130" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementTable", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r228", "r229", "r230", "r265", "r314", "r422", "r423", "r425", "r427", "r649", "r669", "r768", "r776", "r777", "r784", "r785", "r786", "r787", "r788", "r789", "r791", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r808", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r827", "r897", "r899", "r1030", "r1376" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r1049", "r1059", "r1069", "r1101" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Time Based Restricted Stock Units and Profit Interest", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [ "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277" ] }, "us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesDividendReinvestmentPlan", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Dividend Reinvestment Plan", "terseLabel": "Shares issued", "documentation": "Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity." } } }, "auth_ref": [ "r12", "r827", "r858" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Equity shelf program (in shares)", "terseLabel": "Issuance of common stock (in shares)", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r12", "r62", "r63", "r98", "r769", "r827", "r857" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Exchange and redemption of Omega OP Units", "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r12", "r63", "r67", "r68", "r98" ] }, "us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueDividendReinvestmentPlan", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Dividend Reinvestment Plan", "terseLabel": "Gross Proceeds", "documentation": "Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity." } } }, "auth_ref": [ "r12", "r775", "r827", "r858", "r1029", "r1038" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r12", "r62", "r63", "r98", "r775", "r827", "r857", "r1038" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "terseLabel": "Stockholders Equity/AOCI", "totalLabel": "Total stockholders' equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r63", "r67", "r68", "r91", "r793", "r809", "r828", "r829", "r1008", "r1039", "r1170", "r1173", "r1174", "r1202", "r1321", "r1378" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetails", "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets", "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance ending", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r39", "r40", "r48", "r171", "r172", "r173", "r174", "r195", "r228", "r229", "r230", "r232", "r239", "r241", "r327", "r328", "r359", "r420", "r445", "r492", "r507", "r508", "r515", "r516", "r517", "r519", "r524", "r525", "r594", "r595", "r596", "r597", "r598", "r599", "r606", "r638", "r640", "r644", "r648", "r656", "r758", "r759", "r773", "r793", "r809", "r828", "r829", "r859", "r1022", "r1023", "r1038", "r1170", "r1173", "r1174", "r1202", "r1321", "r1378" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r95", "r431", "r433", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r592", "r605", "r830", "r831", "r860" ] }, "ohi_StraightLineAccountsReceivableAndLeaseInducementsWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "StraightLineAccountsReceivableAndLeaseInducementsWriteOffs", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails" ], "lang": { "en-us": { "role": { "documentation": "Straight line accounts receivable and lease inducements write-offs.", "label": "Straight Line Accounts Receivable And Lease Inducements Write Offs", "terseLabel": "Straight line accounts receivable and lease inducements write-offs" } } }, "auth_ref": [] }, "ohi_StraightLineReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "StraightLineReceivables", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesScheduleOfNetAccountsReceivableDetails": { "parentTag": "ohi_ContractualAndOtherReceivablesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesScheduleOfNetAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of excess of income recognized over payment required.", "label": "Straight-line Receivables", "terseLabel": "Straight-line receivables" } } }, "auth_ref": [] }, "ohi_StraightLineRentAndOtherWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "StraightLineRentAndOtherWriteOffs", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent and other write-offs.", "label": "Straight Line Rent And Other Write Offs", "terseLabel": "Straight-line rent and other write-offs" } } }, "auth_ref": [] }, "ohi_StraightLineRentReceivableWriteOffRelatedToPlacingOperatorsOnCashBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "StraightLineRentReceivableWriteOffRelatedToPlacingOperatorsOnCashBasis", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Straight line rent receivable write off related to placing operators on cash basis.", "label": "Straight Line Rent Receivable Write Off Related to Placing Operators on Cash Basis", "terseLabel": "Straight line rent receivable write off related to placing operators on cash basis" } } }, "auth_ref": [] }, "ohi_StraightLineRentReceivableWroteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "StraightLineRentReceivableWroteOff", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesCashBasisOperatorsAndStraightLineReceivableWriteOffsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents wrote off straight line rent receivables.", "label": "Straight Line Rent Receivable Wrote Off" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r645", "r660" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "verboseLabel": "Subsequent event", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r645", "r660" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTable", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r645", "r660" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r645", "r660" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityGenesisDetails", "http://www.omegahealthcare.com/role/DisclosureContractualReceivablesAndOtherReceivablesOperatorCollectibilityMaplewoodDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesSaberHealthHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesShhHoldingsLlcDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r645", "r660" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "verboseLabel": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r659", "r661" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityAtMarketProgramScheduleAndNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureStockholdersEquityScheduleOfDividendReinvestmentAndCommonStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplementalCashFlowElementsAbstract", "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSupplementalDisclosureToConsolidatedStatementsOfCashFlowsDetails2" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Supplemental Information:" } } }, "auth_ref": [] }, "stpr_TN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "TN", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails" ], "lang": { "en-us": { "role": { "label": "Tennessee" } } }, "auth_ref": [] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "TX", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Texas" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r1095" ] }, "ohi_TermLoanDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TermLoanDue2028Member", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Term Loan Due 2028 [Member].", "label": "Term Loan Due 2028 [Member]", "terseLabel": "Term Loan 2028" } } }, "auth_ref": [] }, "ohi_TermLoanFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TermLoanFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureFinancialInstrumentsScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information about fair value of term loan.", "label": "Term Loan Fair Value Disclosure", "verboseLabel": "Term loan" } } }, "auth_ref": [] }, "ohi_ThirtyFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThirtyFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Thirty Facilities [Member].", "label": "30 Facilities" } } }, "auth_ref": [] }, "ohi_ThirtyFourFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThirtyFourFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Thirty Four Facilities [Member].", "label": "34 Facilities" } } }, "auth_ref": [] }, "ohi_ThirtyTwoOfThirtyFourFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThirtyTwoOfThirtyFourFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Thirty Two of Thirty Four Facilities [Member].", "label": "Thirty Two of Thirty Four Facilities [Member]", "terseLabel": "32 of 34 Facilities" } } }, "auth_ref": [] }, "ohi_ThreeAndFourNewNonRealEstateLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThreeAndFourNewNonRealEstateLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Three And Four New Non Real Estate Loan [Member].", "label": "Three And Four New Non Real Estate Loan [Member]" } } }, "auth_ref": [] }, "ohi_ThreeFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThreeFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Three Facilities [Member].", "label": "3 Facilities" } } }, "auth_ref": [] }, "ohi_ThreeNewNonRealEstateLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThreeNewNonRealEstateLoanMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Three New Non Real Estate Loan [Member].", "label": "Three New Non Real Estate Loan [Member]" } } }, "auth_ref": [] }, "ohi_ThreeRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "ThreeRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Three Real Estate Loans [Member].", "label": "Three Real Estate Loans [Member]" } } }, "auth_ref": [] }, "ohi_TimeBasedProfitInterestUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TimeBasedProfitInterestUnitsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Time Based Profit Interest Units [Member].", "label": "Time Based Profit Interest Units [Member]" } } }, "auth_ref": [] }, "ohi_TimeBasedRestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TimeBasedRestrictedStockUnitsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Time Based Restricted Stock Units [Member].", "label": "Time Based Restricted Stock Units [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title and position of individual or group within organization." } } }, "auth_ref": [ "r1196", "r1327" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual with Relationship to Entity [Domain]", "documentation": "Title and position of individual or group within organization." } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableRevolving": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableRevolving", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, revolving.", "label": "Total Gross Write Off Of Receivable, Revolving", "negatedLabel": "Revolving, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableTotal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableTotal", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, total.", "label": "Total Gross Write Off Of Receivable, Total", "negatedTotalLabel": "Total write offs, current period" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearFiveOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearFiveOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, year five, originated, current fiscal year.", "label": "Total Gross Write Off of Receivable, Year Five, Originated, Current Fiscal Year", "negatedLabel": "2022, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearFourOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearFourOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, year four, originated, current fiscal year.", "label": "Total Gross Write Off of Receivable, Year Four, Originated, Current Fiscal Year", "negatedLabel": "2023, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearOneOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearOneOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, year one, originated, current fiscal year.", "label": "Total Gross Write Off of Receivable, Year One, Originated, Current Fiscal Year", "negatedLabel": "2026, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearSixOrMoreYearsBeforeLatestFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearSixOrMoreYearsBeforeLatestFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable year six or more years before latest fiscal year.", "label": "Total Gross Write Off Of Receivable Year Six Or More Years Before Latest Fiscal Year", "negatedLabel": "2020 & older, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearSixOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearSixOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, year six, originated, current fiscal year.", "label": "Total Gross Write Off of Receivable, Year Six, Originated, Current Fiscal Year", "negatedLabel": "2021, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearThreeOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearThreeOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, year three, originated, current fiscal year.", "label": "Total Gross Write Off of Receivable, Year Three, Originated, Current Fiscal Year", "negatedLabel": "2024, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalGrossWriteOffOfReceivableYearTwoOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalGrossWriteOffOfReceivableYearTwoOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": "ohi_TotalGrossWriteOffOfReceivableTotal", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total gross write off of receivable, year two, originated, current fiscal year.", "label": "Total Gross Write Off of Receivable, Year Two, Originated, Current Fiscal Year", "negatedLabel": "2025, current-period gross write-offs" } } }, "auth_ref": [] }, "ohi_TotalRealEstateInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalRealEstateInvestments", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Total amount of real estate investments", "label": "Total Real Estate Investments", "totalLabel": "Total real estate investments" } } }, "auth_ref": [] }, "ohi_TotalReceivableAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableAllowanceForCreditLoss", "crdr": "credit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on total receivable.", "label": "Total Receivable, Allowance for Credit Loss", "totalLabel": "CECL balance, total receivables" } } }, "auth_ref": [] }, "ohi_TotalReceivableAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableAllowanceForCreditLossWriteoff", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of writeoff of total receivable, charged against allowance for credit loss.", "label": "Total Receivable, Allowance for Credit Loss, Writeoff", "negatedTotalLabel": "Write-offs charged against allowance for the period ended, total receivables" } } }, "auth_ref": [] }, "ohi_TotalReceivableBeforeAllowanceForCreditLossTotal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableBeforeAllowanceForCreditLossTotal", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost, before allowance for credit loss, of total receivable.", "label": "Total Receivable, before Allowance for Credit Loss, Total", "totalLabel": "Total receivables" } } }, "auth_ref": [] }, "ohi_TotalReceivableCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableCreditLossExpenseReversal", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleOfExpectedCreditLossPerSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of credit loss expense (reversal of expense) for total receivable.", "label": "Total Receivable, Credit Loss, Expense (Reversal)", "totalLabel": "Provision (Recovery) for Credit Losses, total receivables" } } }, "auth_ref": [] }, "ohi_TotalReceivableOriginatedFiveYearsBeforeLatestFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableOriginatedFiveYearsBeforeLatestFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of total receivable originated five years prior to latest fiscal year.", "label": "Total Receivable Originated Five Years Before Latest Fiscal Year", "totalLabel": "Total 2021" } } }, "auth_ref": [] }, "ohi_TotalReceivableOriginatedSixOrMoreYearsBeforeLatestFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableOriginatedSixOrMoreYearsBeforeLatestFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Total receivable originated six or more years before latest fiscal year.", "label": "Total Receivable Originated Six Or More Years Before Latest Fiscal Year", "totalLabel": "Total 2020 & older" } } }, "auth_ref": [] }, "ohi_TotalReceivableRevolving": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableRevolving", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost of total receivable that can be withdrawn, repaid, and redrawn.", "label": "Total Receivable, Revolving", "totalLabel": "Total receivable Revolving" } } }, "auth_ref": [] }, "ohi_TotalReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost of total receivable originated four years prior to current fiscal year.", "label": "Total Receivable, Year Five, Originated, Four Years before Current Fiscal Year", "totalLabel": "Total 2022" } } }, "auth_ref": [] }, "ohi_TotalReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost of total receivable originated three years prior to current fiscal year.", "label": "Total Receivable, Year Four, Originated, Three Years before Current Fiscal Year", "totalLabel": "Total 2023" } } }, "auth_ref": [] }, "ohi_TotalReceivableYearOneOriginatedCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableYearOneOriginatedCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost of total receivable originated in current fiscal year.", "label": "Total Receivable, Year One, Originated, Current Fiscal Year", "totalLabel": "Total 2026" } } }, "auth_ref": [] }, "ohi_TotalReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost of total receivable originated two years prior to current fiscal year.", "label": "Total Receivable, Year Three, Originated, Two Years before Current Fiscal Year", "totalLabel": "Total 2024" } } }, "auth_ref": [] }, "ohi_TotalReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TotalReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAllowanceForCreditLossesScheduleBySegmentBalanceByVintageAndCreditQualityIndicatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Amortized cost of total receivable originated in fiscal year prior to current fiscal year.", "label": "Total Receivable, Year Two, Originated, Fiscal Year before Current Fiscal Year", "totalLabel": "Total 2025" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1087" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r1094" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r1114" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r1116" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.omegahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ohi_TransitionAgreementPaymentAggregate": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TransitionAgreementPaymentAggregate", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureStockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Transition agreement payment aggregate.", "label": "Transition Agreement Payment Aggregate", "terseLabel": "Transition agreement payment aggregate" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r1117" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r1118" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r1118" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1116" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r1116" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r1119" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r1117" ] }, "ohi_TripleNetInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TripleNetInvestmentsMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsRealEstateImpairmentDetails", "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsScheduleOfPropertiesHeldForSaleDetails", "http://www.omegahealthcare.com/role/DisclosureGoodwillAndOtherIntangiblesNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsScheduleOfSignificantAcquisitionsDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateAssetsSummaryOfConstructionInProgressAndExpenditureInvestmentsBySegmentDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableSummaryOfInvestmentsIncomeDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsReportableSegmentsDetails", "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Triple Net Investments [Member].", "label": "Triple Net Investments [Member]", "terseLabel": "Triple-Net", "verboseLabel": "Triple-Net Investments" } } }, "auth_ref": [] }, "ohi_TwelveNewRealEstateLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TwelveNewRealEstateLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Twelve New Real Estate Loans [Member].", "label": "Twelve New Real Estate Loans [Member]" } } }, "auth_ref": [] }, "ohi_TwentySixFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TwentySixFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Twenty Six Facilities [Member].", "label": "Twenty Six Facilities [Member]", "terseLabel": "26 Facilities" } } }, "auth_ref": [] }, "ohi_TwentySixOfThirtyFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TwentySixOfThirtyFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Twenty Six of Thirty Facilities [Member].", "label": "Twenty Six of Thirty Facilities [Member]", "terseLabel": "26 of 30 Facilities" } } }, "auth_ref": [] }, "ohi_TwentyTwoOfTwentySixFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TwentyTwoOfTwentySixFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Twenty Two of Twenty Six Facilities [Member].", "label": "Twenty Two of Twenty Six Facilities [Member]", "terseLabel": "22 of 26 Facilities" } } }, "auth_ref": [] }, "ohi_TwoNewMortgageLoansRelatedToSalesOfRealEstateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TwoNewMortgageLoansRelatedToSalesOfRealEstateMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Two New Mortgage Loans Related to Sales Of Real Estate [Member].", "label": "Two New Mortgage Loans Related to Sales Of Real Estate [Member]" } } }, "auth_ref": [] }, "ohi_TwoOfThirtyFourFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "TwoOfThirtyFourFacilitiesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureAssetsHeldForSaleDispositionsAndImpairmentsAssetSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Two of Thirty Four Facilities [Member].", "label": "Two of Thirty Four Facilities [Member]", "terseLabel": "2 of 34 Facilities" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r1113" ] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Unsecured debt", "terseLabel": "Total unsecured borrowings - net", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r16", "r111", "r1340" ] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnsecuredDebtMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureBorrowingActivitiesAndArrangementsScheduleOfBorrowingsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Unsecured Debt [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_UtilitiesOperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UtilitiesOperatingExpense", "crdr": "debit", "calculation": { "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails": { "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureSegmentsSignificantExpenseCategoriesBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Utilities Operating Expense", "terseLabel": "Utilities", "documentation": "Amount of operating expense of regulated operation." } } }, "auth_ref": [ "r76" ] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntities" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity Disclosure [Text Block]", "terseLabel": "VARIABLE INTEREST ENTITIES", "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss." } } }, "auth_ref": [ "r100" ] }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "terseLabel": "Maximum exposure to loss", "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)." } } }, "auth_ref": [ "r46", "r104" ] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r527", "r528", "r533", "r534", "r663", "r664", "r665" ] }, "us-gaap_VariableInterestEntityMeasureOfActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityMeasureOfActivityAbstract", "lang": { "en-us": { "role": { "label": "Variable Interest Entities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureConcentrationOfRiskNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureVariableInterestEntitiesScheduleOfVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r42", "r527", "r528", "r533", "r534" ] }, "ohi_VariousFacilityTypesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "VariousFacilityTypesMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureInvestmentsInUnconsolidatedEntitiesScheduleOfEquityMethodInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Various Facility Types [Member].", "label": "Various Facility Types [Member]" } } }, "auth_ref": [] }, "ohi_VestingAndExerciseOfEquityUnitsRelatedToCompensationPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "VestingAndExerciseOfEquityUnitsRelatedToCompensationPlans", "crdr": "debit", "presentation": [ "http://www.omegahealthcare.com/role/StatementConsolidatedStatementsOfEquity" ], "lang": { "en-us": { "role": { "documentation": "Vesting and exercise of equity units related to compensation plans.", "label": "Vesting And Exercise Of Equity Units Related To Compensation Plans", "negatedLabel": "Issuance of Omega OP Units" } } }, "auth_ref": [] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r1083" ] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "WeightedAverageMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureDerivativesAndHedgingDerivativesNotDesignatedAsHedgingInstrumentsDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableGenesisNonRealEstateLoansDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableLoanActivityDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableNarrativeDetails", "http://www.omegahealthcare.com/role/DisclosureRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "documentation": "Average of a range of values, calculated with consideration of proportional relevance." } } }, "auth_ref": [ "r484", "r485", "r612", "r666", "r880", "r881", "r1002", "r1331", "r1333", "r1336" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "verboseLabel": "Common stock equivalents", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r1181" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number Of Shares Outstanding, Diluted", "totalLabel": "Denominator for diluted earnings per share", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r248", "r258" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator:", "verboseLabel": "Weighted-average shares outstanding, Basic and Diluted" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.omegahealthcare.com/role/DisclosureEarningsPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number Of Shares Outstanding, Basic", "terseLabel": "Denominator for basic earnings per share", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r246", "r258" ] }, "ohi_WorkingCapitalLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.omegahealthcare.com/20260630", "localname": "WorkingCapitalLoansMember", "presentation": [ "http://www.omegahealthcare.com/role/DisclosureNonRealEstateLoansReceivableScheduleOfReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Working Capital Loans [Member].", "label": "Working Capital Loans [Member]" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r1081" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21B", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21B" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org/310/tableOfContent" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-24" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/230/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "970", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/970/tableOfContent" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "972", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/972/tableOfContent" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "974", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/974/tableOfContent" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "976", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/976/tableOfContent" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "978", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/978/tableOfContent" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "323", "Publisher": "FASB", "URI": "https://asc.fasb.org/323/tableOfContent" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column C", "Footnote": "5", "Publisher": "SEC" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column C", "Footnote": "4", "Publisher": "SEC" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column C", "Footnote": "2", "Publisher": "SEC" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column F", "Footnote": "7", "Publisher": "SEC" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Footnote": "4", "Publisher": "SEC" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Footnote": "5", "Publisher": "SEC" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "3", "Publisher": "SEC" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "4", "Publisher": "SEC" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column B", "Publisher": "SEC" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column C", "Publisher": "SEC" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "m", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "m", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "M", "Paragraph": "Question 2", "Publisher": "SEC" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SAB Topic 1.B.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-6A" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2A" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/310-10/tableOfContent" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "44", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-44" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/310-20/tableOfContent" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-6" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482454/460-10-45-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(24)(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10B" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2AG", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AG" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEE", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEE", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEE", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4F", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4I" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "15", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480960/815-15-50-3" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479016/842-30-45-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "805", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "974", "SubTopic": "720", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477728/974-720-50-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r883": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r884": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10" }, "r885": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r886": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r887": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-3A" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-15" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-79" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r924": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r925": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r926": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r927": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r928": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r929": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r930": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "64", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64" }, "r931": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r932": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r933": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r934": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r936": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r937": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r938": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-3" }, "r939": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r940": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r941": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "39", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39" }, "r942": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41" }, "r943": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "43", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43" }, "r944": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47" }, "r945": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r946": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r947": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r948": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r949": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r950": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r951": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r952": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r953": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r954": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29" }, "r955": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29" }, "r956": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r957": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r958": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r959": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r960": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r961": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r962": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r963": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r964": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r965": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r966": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r967": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r968": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r969": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r970": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r971": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r972": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r973": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13" }, "r974": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r975": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r976": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r977": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r978": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r979": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r980": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r981": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r982": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r983": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r984": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r985": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r986": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r987": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r988": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r989": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r990": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r991": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r992": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r993": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r994": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r995": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "181", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181" }, "r996": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r997": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "183", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-183" }, "r998": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "184", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184" }, "r999": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "185", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-185" }, "r1000": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1006": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12" }, "r1007": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r1008": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r1009": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r1010": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r1011": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r1012": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r1013": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r1014": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r1015": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r1016": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r1017": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "942", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479255/942-310-S50-4" }, "r1018": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "942", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.H.2.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478116/942-310-S99-2" }, "r1019": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r1020": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1021": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1022": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11" }, "r1023": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14" }, "r1024": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14" }, "r1025": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9" }, "r1026": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r1027": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1028": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r1029": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479083/946-230-55-1" }, "r1030": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r1031": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1032": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1033": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1034": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r1035": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r1036": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1037": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r1038": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r1039": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r1040": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1041": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1042": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1043": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r1044": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1045": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1046": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1047": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1048": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1049": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1050": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1051": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1052": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1053": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1054": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1055": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1056": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1057": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1058": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1059": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1060": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1061": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1062": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1063": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1064": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1065": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1066": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1067": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1068": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1069": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1070": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1071": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1072": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1073": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1074": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1075": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1076": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1077": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1078": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1079": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1080": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r1081": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r1082": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r1083": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r1084": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r1085": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r1086": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r1087": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1088": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1089": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1090": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1091": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1092": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1093": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1094": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1095": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1096": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1097": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1098": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1099": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1100": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1101": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1102": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1103": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1104": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1105": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1106": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1107": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1108": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1109": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1110": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1111": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1112": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1113": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1114": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1115": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1116": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1117": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1118": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1119": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1120": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1121": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r1122": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r1123": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r1124": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r1125": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1126": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r1127": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1128": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1129": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1130": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r1131": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "SubTopic": "310", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1132": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r1133": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r1134": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r1135": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r1136": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r1137": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r1138": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r1139": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r1140": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r1141": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1142": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r1143": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r1144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "6", "Subsection": "04", "Paragraph": "12", "Subparagraph": "(b)(1)", "Publisher": "SEC" }, "r1147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r1148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r1159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12" }, "r1160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15" }, "r1161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r1162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r1163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r1164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r1165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r1167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r1170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r1171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r1172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r1177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r1178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r1179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r1180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r1181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r1183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r1184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r1190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/310-10/tableOfContent" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r1204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r1205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r1206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r1207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r1208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r1232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r1233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r1238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r1239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r1241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r1247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r1249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-15" }, "r1250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r1251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1257": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1258": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1259": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1260": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1261": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1262": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1263": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1264": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1265": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1266": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1267": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1268": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1269": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1270": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1271": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1272": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r1279": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r1280": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1281": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r1282": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1283": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1284": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1285": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1286": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r1287": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7" }, "r1288": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r1289": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3" }, "r1290": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1291": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r1292": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1293": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1294": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1295": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1296": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r1297": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r1298": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A" }, "r1299": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1300": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1301": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1302": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r1303": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1304": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1305": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1306": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1307": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1308": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1309": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r1317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13" }, "r1320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r1323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r1324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r1328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-18" }, "r1329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r1338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" } } }